Stockwinners Market Radar for May 15, 2023 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service |
GATO | Hot Stocks20:26 EDT Gatos Silver to delay Q1 financial statements - Gatos Silver "announced it will be delayed in filing its Quarterly Report on Form 10-Q for the period ended March 31, 2023 which includes the unaudited interim financial statements as at March 31, 2023 of the Company and the Los Gatos Joint Venture. The delay results from a previously disclosed, ongoing review of filed financial statements of the Company and of the LGJV for the year ended December 31, 2021 and the quarters ended March 31, 2022, June 30, 2022 and September 30, 2022. The Company expects to adjust and restate r (i) its and the LGJV's financial statements in respect of the timing and recognition of net deferred tax assets and liabilities at the LGJV and (ii) its financial statements from the impact of the timing and recognition of the priority distribution obligation and subsequent payments on the previously recognized income from affiliates."
|
HOOD | Hot Stocks20:06 EDT Cathie Wood's ARK Investment bought 140K shares of Robinhood today
|
TOST | Hot Stocks20:06 EDT Cathie Wood's ARK Investment bought 100K shares of Toast today
|
HOOD | Hot Stocks19:55 EDT Robinhood exec sells $918K in common stock - Robinhood disclosed that its Chief Creative Officer Baiju Bhatt sold 96.5K shares of common stock on May 11th in a total transaction size of $918K.
|
ACLX | Hot Stocks19:05 EDT Arcellx director sells $28.7M in common stock - In a regulatory filing, Arcellx disclosed that its director Jill Carroll sold 638.4K shares of common stock on May 11th in a total transaction size of $28.7M.
|
INZY | Hot Stocks18:57 EDT Inozyme director buys $2.85M in common stock - In a regulatory filing, Inozyme disclosed that its director Robert Hopfner bought 448K shares of common stock on May 11th in a total transaction size of $2.85M as part of option expiry.
|
CISO | Hot Stocks18:38 EDT CISO forms vCISO to own certain intellectual property of the company - CISO Global announced that it has formed vCISO to own and out-license certain intellectual property of the company. The ARGO Security Management Platform will be the first asset moved to the wholly owned subsidiary. ARGO provides a holistic view of a company's information security program on a single pane of glass. Designed to empower both security professionals and non-technical executives with real-time data to see how vital components of their security program are performing, ARGO has been successfully deployed on customer networks. CISO expects to move additional intellectual property to vCISO on an ongoing basis.
|
RDHL | Hot Stocks18:19 EDT RedHill Biopharma receives Nasdaq notification over minimum market value - RedHill Biopharma announced that it has received a written notification from the Nasdaq Stock Market LLC dated May 9, 2023 indicating that the Company is not in compliance with the minimum Market Value of Publicly Held Shares set forth in the Nasdaq Rules for continued Nasdaq listing. Nasdaq Listing Rule 5450(b)(3)(C) requires companies to maintain a minimum MVPHS of $15M, and Listing Rule 5810(c)(3)(D) provides that a failure to meet the MVPHS requirement exists if the deficiency continues for a period of 30 consecutive business days. This notification does not impact the listing and trading of the Company's securities at this time. Pursuant to Nasdaq Listing Rule 5810(c)(3)(D), the Company has a compliance period of 180 calendar days (or until November 6, 2023) to regain compliance. If at any time during this compliance period the Company's MVPHS closes at $15M or more for a minimum of ten consecutive business days, Nasdaq will notify the Company that it has achieved compliance with the MVPHS requirement, and the MVPHS matter will be closed. In the event the Company does not regain compliance with Rule 5450(b)(3)(C) prior to the expiration of the compliance period, it will receive written notification that its securities are subject to delisting. Alternatively, the Company may consider applying to transfer its securities to the Nasdaq Capital Market.
|
VOXX | Hot Stocks18:09 EDT Voxx falls 20% to $9.60 after Q4 loss - Commenting on the company's results and business outlook, Pat Lavelle, CEO stated, "While we had a lot of positive developments and continued to win new business and expand globally, Fiscal 2023 was certainly a challenging year. From inflation, fears of recessions across the globe, the retail environment and ongoing supply chain constraints, we faced a myriad of roadblocks this year and our results came in lower than expected. We're anticipating continued softness in the global economy and at retail, though chip availability has improved which should positively impact our Automotive business. We continued to grow the Onkyo and Pioneer business and have plans to expand our footprint globally this year. Additionally, our Biometrics segment should show considerable improvement with new accounts awarded and several projects underway."
|
MSFT ATVI | Hot Stocks18:03 EDT U.K.'s CMA says it 'stands by' decision on Microsoft-Activision deal - The U.K.'s Competition and Markets Authority responded to the European Commission approval of Microsoft's (MSFT) proposed takeover of Activision Blizzard (ATVI): "The UK, US and European competition authorities are unanimous that this merger would harm competition in cloud gaming. The CMA concluded that cloud gaming needs to continue as a free, competitive market to drive innovation and choice in this rapidly evolving sector. Microsoft's proposals, accepted by the European Commission today, would allow Microsoft to set the terms and conditions for this market for the next 10 years. They would replace a free, open and competitive market with one subject to ongoing regulation of the games Microsoft sells, the platforms to which it sells them, and the conditions of sale. This is one of the reasons the CMA's independent panel group rejected Microsoft's proposals and prevented this deal. While we recognise and respect that the European Commission is entitled to take a different view, the CMA stands by its decision." Reference Link
|
GOLF | Hot Stocks18:03 EDT Acushnet Holdings exec sells $1.54M in common stock - In a regulatory filing, Acushnet Holdings disclosed that its exec Mary Louise Bohn sold 30K shares of common stock on May 11th in a total transaction size of $1.54M.
|
GOOGL... | Hot Stocks17:49 EDT Third Point buys Alibaba, cuts AIG in Q1 - Third Point LLC disclosed in an SEC filing its holdings as of March 31, 2023. The fund's 14 new buys during the first quarter included, by size of position, Alphabet Class A (GOOGL), HCA Healthcare (HCA), Salesforce (CRM), Alibaba (BABA), and National Instruments (NATI). Third Point exited 12 positions during the quarter, including by size of previous position TJX (TJX), Ovintiv (OVV), Fidelity National Information Services (FIS), Disney (DIS), and LabCorp (LH). The fund increased its stake in seven holdings, including by size of previous position DuPont (DD), Hertz (HTZ), PG&E (PCG), International Flavors and Fragrances (IFF), and Danaher (DHR). Third Point reduced its stake in four holdings, including by size of previous position UnitedHealth (UNH), AIG (AIG), Colgate-Palmolive (CL), and Microsoft (MSFT). The fund's top holdings as of March 31, in order of size, were PG&E, Colgate-Palmolive, Danaher, Bath & Body Works (BBWI), and Alphabet Class A.
|
KDP | Hot Stocks17:42 EDT Keurig Dr Pepper exec buys $186.4K in common stock - In a regulatory filing, Keurig Dr Pepper disclosed that its General Counsel Anthony Shoemaker bought 82K shares of common stock on May 11th in a total transaction size of $186.4K.
|
GOEV | Hot Stocks17:40 EDT Canoo sees Q2 CapEx $10M-$20M - Sees Q2 operating expenses, excluding stock-based compensation and depreciation, $40M-$60M.
|
GOOG... | Hot Stocks17:19 EDT Pershing Square take new stake in Alphabet, cuts position in Lowe's - Bill Ackman's Pershing Square Capital Management disclosed in an SEC filing its holdings as of March 31, 2023. Pershing Square's new buys during the first quarter included, by size of position, Alphabet (GOOG) and Alphabet (GOOGL). Pershing Square increased its stake in multiple holdings, including by size of previous position, Howard Hughes (HHC) and Canadian Pacific Kansas City (CP). Pershing Square reduced its stake in Lowe's (LOW). Pershing Square's top holdings as of March 31, in order of size, were Lowe's, Chipotle Mexican Grill (CMG), Restaurant Brands (QSR), Hilton Worldwide (HLT), and Howard Hughes.
|
SERA | Hot Stocks17:15 EDT Sera Prognostics CEO Greg Critchfield to retire - Sera Prognostics "announced the retirement of the Company's President and CEO, Gregory C. Critchfield, M.D., M.S. Dr. Critchfield is retiring after 12 years of dedicated and valuable service to the Company. Dr. Critchfield plans to step down from his executive role effective June 8, 2023, to pursue other activities. Zhenya Lindgardt, a member of the Company's Board of Directors, will succeed Dr. Critchfield, as Interim CEO & President. Kim Kamdar, Ph.D., a member of the Board, has been appointed as Chair of the Board. Dr. Critchfield continues his service as a member of the Board."
|
TOST | Hot Stocks16:58 EDT Toast director sells $1.1M in common stock - In a regulatory filing, Toast disclosed that its director Mark Hawkins sold 52.8K shares of common stock on May 11th in a total transaction size of $1.1M.
|
SMCI | Hot Stocks16:57 EDT Super Micro Computer director buys $401.6K in common stock - In a regulatory filing, Super Micro Computer disclosed that its director Shiu Leung Chan bought 3K shares of common stock on May 11th in a total transaction size of $401.6K
|
GEHC... | Hot Stocks16:57 EDT Trian Fund buys GE Healthcare, exits Sysco in Q1 - Nelson Peltz's Trian Fund Management disclosed in an SEC filing its holdings as of March 31, 2023. The fund's one new buy during the first quarter was GE Healthcare (GEHC). Trian exited one position during the quarter, namely Sysco (SYY). Trian increased its stake in two hldings, including by size of previous position General Electric (GE) and Mondelez (MDLZ). The fund reduced its stake in two holdings, including by size of previous position Invesco (IVZ) and Disney (DIS). Trian's top holdings as of March 31, 2023, in order of size, were Janus Henderson (JHG), Disney, Invesco, Wendy's (WEN), and GE.
|
RMBL | Hot Stocks16:50 EDT RumbleON appoints Steven Pully to its Board, effective May 11 - RumbleOn announced the appointment of Mr. Steven J. Pully to its Board of Directors effective May 11. Mr. Pully is an experienced board member, investment banker, restructuring professional and corporate executive. He has served on over 35 boards over the course of his career across a wide range of industries, including retail, entertainment, manufacturing, technology, and energy and power. Mr. Pully's appointment follows a number of corporate governance enhancements recently implemented by the RumbleOn Board to bolster its diversity and expertise. Mr. Pully was proposed as a nominee by shareholders and former Board members, Bill Coulter and Mark Tkach, and he replaces Peter Levy, who recently resigned from the Board. With the addition of Mr. Pully, all seats on the Company's Board are again filled. Mr. Pully will serve on the Audit Committee of the Board. "We are pleased that Steve promptly accepted our invitation to meet with the Nominating and Corporate Governance Committee
|
GEG GECC | Hot Stocks16:48 EDT Great Elm Group CFO Pearson resigns, Davis named next CFO - Great Elm Group (GEG) announced that Brent Pearson resigned as Chief Financial Officer. The Board of Directors unanimously appointed Keri Davis as CFO effective immediately. With the assumption of the CFO position at GEG, Ms. Davis expands her role with the Company as she continues in her capacity as CFO of Great Elm Capital Corp. (GECC), a business development company managed by a subsidiary of GEG. "On behalf of the Company and the Board, I am thrilled to have Keri expand her role to CFO of GEG as we reposition our focus on alternative asset management," said Jason Reese, CEO and Chairman of the GEG Board. "Keri's experience working with asset management companies makes her uniquely qualified to lead the finance and accounting team at GEG. I want to take the opportunity to thank Brent Pearson for his service and contributions to Great Elm."
|
DAC | Hot Stocks16:48 EDT Danaos appoints Dimitris Vastarouchas as COO and Filippos Prokopakis as CCO - Danaos announced that Iraklis Prokopakis will retire from his executive role as Senior Vice President and COO during the Q4. Prokopakis, who has served in this position since 1998, will remain on the Board of Directors and will pursue his academic interests following his retirement. The position of COO will be assumed by Dimitris Vastarouchas who currently serves as Deputy COO of Danaos. Vastarouchas joined Danaos Shipping in 1995. He was promoted to Technical Director of our Manager in 2005 and has served as Deputy Chief Operating Officer of Danaos for the last 12 years. Additionally, Filippos Prokopakis, who currently serves as Commercial Director of our Manager, will be appointed as CCO of Danaos. Filippos has been with our Manager since 2012 and has considerable expertise across all commercial operations.
|
GMED | Hot Stocks16:41 EDT Globus Medical receives FDA clearance for Reflect Scoliosis Correction System - Globus Medical announced the Reflect Scoliosis Correction System has been granted approval from the FDA, as the company's first humanitarian device. Reflect is designed to correct progressive scoliosis in young patients while preserving motion, maintaining stability, and allowing for future modulated growth.
|
RSVR... | Hot Stocks16:36 EDT Elliott bought Reservoir Media in Q1, sold Aerojet and News Corp. - Paul Singer's Elliott Investment Management disclosed in an SEC filing its holdings as of March 31, 2023. Elliott made one new buy during the quarter - 401,546 shares of Reservoir Media (RVSR). The fund exited four positions: SPDR Bloomberg High Yield Bond ETF (JNK), Aerojet Rocketdyne (AJRD), News Corp. Class B (NWS) and News Corp. Class A (NWSA). Elliott increased its holdings in two names, including Triple Flag Precious Metals (TFPM). The fund decreased five positions, including by size, Howmet Aerospace (HWM), Valaris (VAL), Peabody Energy (BTU) and Polestar Automotive (PSNY). Elliott's top holdings as of March 31 were Triple Flag Precious Metals, Marathon Petroleum (MPC), Howmet Aerospace, Pinterest (PINS) and Peabody.
|
HOFV | Hot Stocks16:35 EDT Hall of Fame Resort & E. reports Q1 revenue $3.1M, up 48% from last year - Reports Q1 adjusted EBITDA loss $12.0M, compared to a loss of $6.7M in the same period in the prior year. "Our primary focus remains on driving revenue growth through the creation of assets and new content for our guests to enjoy. This spring, we hosted over one hundred thousand people on campus for various sporting and entertainment events, signed several compelling media deals, and have continued to establish our brand within the gaming space. We are transitioning from necessary pre-opening launch expenses into a more efficient cost model with refinement of ongoing operations across our company. Executing our strategy to drive synergistic revenue growth and expense management will lead to future profitability," said Michael Crawford, HOFV President and CEO.
|
BKI... | Hot Stocks16:32 EDT Greenlight Capital exits positions in Victoria's Secret, Funko - David Einhorn's Greenlight Capital disclosed in an SEC filing its holdings as of March 31, 2023. Greenlight's eight new buys during the first quarter included, by size of position, Black Knight (BKI), First Citizens BancShares (FCNCA), and New York Community Bancorp (NYCB). Greenlight exited ten positions during the quarter, including by size of previous position, Victoria's Secret (VSCO), Funko (FNKO), CNX Resources (CNX), and 23andMe (ME). Greenlight increased its stake in eleven holdings, including by size of previous position, Tenet (THC), Consol Energy (CEIX), Global Payments (GPN), Gulfport Energy (GPOR), and Concentrix (CNXC). Greenlight reduced its stake in eleven holdings, including by size of previous position, Brighthouse Financial (BHF), Resideo (REZI), Southwestern Energy (SWN), ODP Corp (ODP), and Galapagos (GLPG). Greenlight's top holdings as of March 31, in order of size, were Green Brick (GRBK), Consol Energy, Brighthouse, Kyndryl (KD), and Teck Resources (TECK).
|
KWEB... | Hot Stocks16:28 EDT Paulson exits Bidu, cuts Horizon Therapeutics in Q1 - John Paulson's Paulson & Co. disclosed in an SEC filing its holdings as of March 31, 2023, The fund exited five positions during the quarter, including by size of previous position KraneShares CSI China Internet ETF (KWEB), SSR Mining (SSRM), Overseas Shipholding (OSG), and Baidu (BIDU). Paulson decreased its holding in one position, namely Horizon Therapeutics (HZNP). The fund's top holdings as of March 31, 2023, in order of size, were Bausch Health (BHC), Brightsphere (BSIG), Novagold (NG), Perpetua Resources (PPTA), and Horizon Therapeutics.
|
NVTS | Hot Stocks16:27 EDT Navitas Semiconductor sees FY23 revenue to double - Second quarter 2023 net revenues are expected to increase, in the range of $16M to $17M, and full-year 2023 revenue is still expected to double compared to 2022. Gross margin for the second quarter is expected to increase by between 25 and 50 basis points, and expand incrementally throughout the year, exiting 2023 in the mid-40s percent. Non-GAAP operating expenses, excluding stock-based compensation and amortization of intangible assets, are expected to be approximately $19 million in the second quarter of 2023 and are projected to grow in the mid-high single digits on a quarterly basis throughout the year but decline on a percentage of revenue basis as the business scales. Weighted-average basic share count is expected to be approximately 162 million shares at the end of the second quarter of 2023.
|
COF... | Hot Stocks16:26 EDT Berkshire Hathaway takes stake in Capital One, exits RH - Berkshire Hathaway disclosed in an SEC filing its holdings as of March 31. Berkshire Hathaway's two new buys during the first quarter included, by size of position, Capital One (COF) and Diageo (DEO). Berkshire Hathaway exited four positions during the quarter, including by size of previous position, BNY Mellon (BNY), RH (RH), TSMC (TSM), and US Bancorp (USB). Berkshire increased its stake in seven holdings, including by size of previous position, Apple (AAPL), Occidental Petroleum (OXY), HP Inc (HPQ), Paramount Global Class B (PARA), Citigroup (C), and Markel (MKL). Berkshire reduced its stake in eight holdings, including by size of previous position, Chevron (CVX), McKesson (MCK), General Motors (GM), Celanese (CE), Ally Financial (ALLY), Aon (AON), Amazon.com (AMZN), and Activision Blizzard (ATVI). Berkshire's top holdings as of March 31, in order of size, were Apple, Bank of America (BAC), American Express (AXP), Coca-Cola (KO), and Chevron.
|
ILMN... | Hot Stocks16:25 EDT Icahn bought Illumina in Q1, sold shares of Herc and Newell - Carl Icahn's Icahn Enterprises (IEP) disclosed in an SEC filing its holdings as of March 31, 2023. Icahn made one new purchase in the quarter, buying 430,000 shares of Illumina (ILMN). The firm increased its holdings in two names, including 3.91M shares of Southwest Gas (SWX). Icahn decreased two holdings, selling 3.17M shares of Herc Holdings (HRI) and 3.08M shares of Newell Brands (NWL). The firm's top holdings as of March 31, in order of size, were Icahn Enterprises, CVR Energy (CVI), FirstEnergy (FE), Southwest Gas and Xerox (XRX).
|
FDX... | Hot Stocks16:20 EDT Appaloosa takes stake in FedEx, exits Aptiv - Appaloosa disclosed in an SEC filing its holdings as of March 31, 2023. Appaloosa's new buys during the first quarter included, by size of position, FedEx (FDX), Nvidia (NVDA), Tesla (TSLA), and Ark Innovation ETF (ARKK). Appaloosa exited one position during the quarter, Aptiv (APTV). Appaloosa increased its stake in seven holdings, including by size of previous position, Uber (UBER), Amazon.com (AMZN), Meta Platforms (META), Alphabet Class C (GOOGL), Microsoft (MSFT), Antero Resources (AR) and Macy's (M). Appaloosa reduced its stake in three holdings, including by size of previous position, Constellation Energy (CEG), HCA Healthcare (HCA), and Salesforce (CRM). Appaloosa's top holdings as of March 31, in order of size, were Alphabet Class C, Amazon.com, Uber, Constellation Energy, and Meta Platforms.
|
PX | Hot Stocks16:19 EDT P10 boosts annual dividend 8% to 13c per share - The Company has approved an 8% increase in the annual dividend, from 12c per share to 13c per share. The Board of Directors of the Company has declared a quarterly cash dividend of 3.25c per share of Class A and Class B common stock, payable on June 20 to the holders of record as of the close of business on May 30. Robert Alpert, Chairman and Co-CEO, and Co-CEO Clark Webb said, "P10 delivered strong first quarter results amid a challenging macroeconomic environment. We added $911 million to fee paying assets under management. With double-digit growth in revenue, Adjusted EBITDA, and Adjusted Net Income, we believe the company is well positioned for continued growth from an array of complementary and expanding businesses."
|
VHC | Hot Stocks16:16 EDT VirnetX receives non compliance letter from NYSE - VirnetX Holding announced that on May 12 it received a notice from the New York Stock Exchange that the Company's common stock is not in compliance with Rule 802.01C of the NYSE's Listed Company Manual relating to the minimum average closing price of the Company's common stock required over a consecutive 30 trading-day period. The NYSE notification does not affect the Company's business operations or its Securities and Exchange Commission reporting requirements. Under the NYSE standards, the Company can regain compliance with Rule 802.01C if, during the six-month period following receipt of the NYSE notice, on the last trading-day of any calendar month, the Company's common stock has a closing price per share of at least $1.00 and a 30 trading-day average closing share price of at least $1.00. The Company intends to cure the price deficiency and return to compliance with Rule 802.01C within the applicable cure period.
|
KKR... | Hot Stocks16:14 EDT Lone Pine boosts Salesforce stake, reduces Visa, Mastercard stakes - Stephen Mandel's Lone Pine Capital disclosed in an SEC filing its holdings as of March 31, 2023. Lone Pine's two new buys during the first quarter included, by size of position, KKR & Co (KKR) and Bill Holdings (BILL). Lone Pine exited three positions during the quarter, including by size of previous position, Thermo Fisher (TMO), First Citizens BancShares (FCNCA), and Equifax (EFX). Lone Pine increased its stake in eight holdings, including by size of previous position, Salesforce (CRM), ASML (ASML), Floor & Decor (FND), EPAM Systems (EPAM), and Valaris (VAL). Lone Pine reduced its stake in 14 holdings, including by size of previous position, Bath & Body Words (BBWI), UnitedHealth (UNH), Amazon (AMZN), Visa (V), and Mastercard (MA). Lone Pine's top holdings as of March 31, in order of size, were Workday (WDAY), Microsoft (MSFT), Taiwan Semiconductor (TSM), Bath & Body Works, and Amazon.
|
BRKR | Hot Stocks16:12 EDT Bruker announces two-year share buyback of up to $500M - Bruker Corporation announced that on May 12, 2023, its Board of Directors approved a new share repurchase authorization for the purchase of up to $500M of the company's common stock over a two-year period commencing on May 15, 2023. The share repurchase authorization permits shares to be repurchased under open market purchases, accelerated share repurchases, or pursuant to trading plans intended to qualify under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The share repurchase authorization does not obligate the Company to repurchase any specific number of shares and may be suspended, modified or terminated at any time without prior notice. "Bruker's strong financial performance, outlook, and balance sheet continues to support a flexible capital allocation strategy with our goal of maximizing shareholder value creation over the long term," said Gerald Herman, Executive Vice President and Chief Financial Officer of Bruker. "This new share repurchase authorization provides flexibility to selectively return capital to our shareholders while continuing to prioritize investments which enable innovation and sustainable growth over time, including in our high-growth, high-margin, Project Accelerate 2.0 initiatives."
|
NOG | Hot Stocks16:11 EDT Northern Oil and Gas to acquire 30% stake in Forge Assets in Delaware Basin - Northern Oil and Gas announced that it has entered into a definitive agreement to acquire a 30% undivided stake in the Forge Assets in the Delaware Basin, in partnership with Vital Energy, Inc., for a purchase price net to NOG of $162.0 million in cash, subject to typical closing adjustments. The Acquired Assets are primarily located in Ward and Reeves Counties, Texas and include approximately 10,200 net acres, 30.5 net producing wells, 2.3 net wells-in-process and ~20 low-breakeven net undeveloped locations. Upon closing, the operator of the assets will be Vital, with NOG participating in development pursuant to cooperation and joint operating agreements entered into with Vital in connection with the acquisition. Recent production on the Acquired Assets was approximately 3,400 Boe per day (2-stream, 79% oil). For the second half of 2023, NOG expects average production of greater than3,750 Boe per day (2-stream, 79% oil) and approximately $17 million of capital expenditures. The effective date for the transaction is March 1, 2023, and NOG expects to close the transaction at the end of June 2023. The obligations of the parties to complete the transactions contemplated by the purchase agreement are subject to the satisfaction or waiver of customary closing conditions.
|
NVTA NTRA | Hot Stocks16:11 EDT Invitae to appeal jury's veredict in Natera patent case - Invitae (NVTA) announced that it intends to appeal the verdict delivered by a jury at the U.S. District Court for the District of Delaware. The jury found that Invitae's products using Anchored Multiplex PCR, or AMP, chemistry infringe certain Natera (NTRA) patents. The jury awarded Natera a total of $19.35M, based on lost profits and a royalty rate of 10% on certain products. Invitae will vigorously defend itself in future proceedings regarding Natera's request for injunctive relief. In response to the verdict, Invitae President and CEO Ken Knight said, "We continue to have strong confidence in our product portfolio and our freedom to operate based on the unique and distinguished nature of our technology, and expect to demonstrate that in ongoing proceedings. We believe that it is important to provide options for cancer patients, clinicians and healthcare systems. To that end, we are committed to bringing an effective and differentiated Personalized Cancer Monitoring, or PCM, solution to market."
|
AA | Hot Stocks16:11 EDT Alcoa, Emirates Global Aluminum sign long-term alumina supply deal - Alcoa and Emirates Global Aluminum announced a new multi-year agreement for Alcoa to supply EGA with smelter grade alumina. Over the life of the 8-year agreement, which commences in 2024, volume options will allow EGA to procure as much as 15.6 million metric tons of alumina from Western Australia. The supply agreement will represent a significant portion of Alcoa's annual third-party alumina sales. The supply agreement will make Alcoa EGA's largest third-party supplier of alumina. EGA's Al Taweelah alumina refinery in Abu Dhabi met 47 percent of EGA's total alumina needs in 2022. "Alcoa operates the world's largest third-party alumina business with low-carbon processes, and we're proud to be recognized with this significant additional volume from EGA as a leading global producer," said Alcoa President and CEO Roy Harvey. "The agreement is the largest alumina supply contract ever signed between Alcoa and EGA, and it will strengthen the long-term supply relationship between our two companies."
|
CZOO | Hot Stocks16:09 EDT Cazoo EU exit complete following Cluno sale - Cazoo Group announced the completion of the sale of its German subscription business, Cluno GmbH, to ViveLaCar GmbH and The Platform Group GmbH & Co. KG. The financial terms of the transaction were not disclosed. The agreement includes 100% of the capital and voting rights of the company Cluno GmbH and the Cluno brand along with the associated assets. All employees of Cluno have transferred to ViveLaCar GmbH as part of the agreement. This transaction, together with previously announced sales and winddown of other businesses and assets in Europe, concludes the withdrawal of Cazoo from mainland Europe.
|
ALIT | Hot Stocks16:07 EDT Alight target mid-term annual total revenue growth of 6%-8% - Over the medium term, the company targets: "Annual BPaaS revenue growth of 15%+; Annual total revenue growth of 6%-8%; Employer Solutions adjusted gross margin increase of 300-400 bps; Adjusted EBITDA margin increase of 400-500 bps; Operating cash flow conversion of 60-80%." CEO Stephan Scholl states: "During our Investor Day, we showcased how we are radically changing the way employees engage with their benefits and wellbeing programs by creating a differentiated and personalized experience that directly impacts costs for the individual and employer. We believe we are well-positioned to continue executing on our go-to market strategy and driving shareholder value creation."
|
SPWR | Hot Stocks16:06 EDT SunPower appoints Elizabeth Eby as CFO - SunPower announced that Elizabeth "Beth" Eby has been appointed as its CFO, effective May 30. Eby is a seasoned executive who brings more than 30 years of experience in financial strategy, execution and governance at Fortune 50 and publicly traded technology companies. As CFO, Eby will play a critical role in developing and implementing the company's strategic growth plan and in leading SunPower's finance organization and activities. Eby most recently served as CFO of NeoPhotonics Corporation, a worldwide leader in high-speed digital optics. Prior to that, she grew her career at Intel Corporation, where she held several senior roles during her more than 25-year tenure, including Vice President of Finance and Group CFO for the Internet of Things business. She holds a Bachelor of Science degree in Mathematics from the University of Michigan and a Master of Science in Industrial Administration (MBA) from Carnegie Mellon University.
|
CYAD | Hot Stocks16:04 EDT Celyad discloses Nasdaq delisting notice - The Company had previously announced on April 4th, 2023, that The Nasdaq Stock Market notified the Company on March 31st, 2023 that it failed to maintain the continued listing requirement under Nasdaq Listing Rule 5450(b)(1)(A) for the Nasdaq Global Market, which requires that a listed company's stockholders' equity be at least $10.0 million. Further, on April 19th, 2023, as announced by the Company on April 24th, 2023, the Company received a notice from Nasdaq informing the Company that the minimum closing bid price per share of its American Depositary Shares representing ordinary shares was below $1.00 for a period of 30 consecutive business days and that the Company did not meet the minimum bid price requirement set forth in Nasdaq Listing Rule 5450(a)(1). On May 5th, 2023, the Company announced that its Board of Directors approved the voluntary delisting of its ADSs from the Nasdaq Global Market. On May 10th, 2023, the Company received a notification letter from Nasdaq, advising the Company that its ADSs are scheduled for delisting from The Nasdaq Global Market and will be suspended at the opening of U.S. business on May 19th, 2023. The Notice stated that Nasdaq has determined that the Company did not provide a definitive plan evidencing its ability to achieve near term compliance with the continued listing requirements or sustain such compliance over an extended period of time. The Company does not intend to appeal Nasdaq's determination and, therefore, it is expected that the Company's ADSs will be delisted from the Nasdaq Global Market on May 19th, 2023. A Form 25-NSE will be filed with the U.S. Securities and Exchange Commission, which will remove the Company's ADSs from listing on Nasdaq. The Company will continue to be listed on Euronext Brussels. Whether or not the Company's ADSs will be traded on the over-the-counter market thereafter will depend on the actions of shareholders and independent third parties, without the Company's involvement."
|
CSSE | Hot Stocks16:02 EDT Chicken Soup for the Soul enters global agreement with TaTaTu - Chicken Soup for the Soul "announced it has signed a global content agreement with Rome-based entertainment and social media platform TaTaTu. TaTaTu will launch its service via the unique TaTaTu app available for iOS and Android devices using Chicken Soup for the Soul Entertainment-owned movies, television series, and documentaries. TaTaTu is the first platform to reward users with coins for social media activities and viewing content. Users can earn coins by watching movies and TV series for free, posting videos and photos, and earn even more TTU Coins when someone likes, comments, views, chats, or shares a post or when users invite a friend. The coins can then be used to bid on auctions for products or experiences - or exchanged for e-commerce products."
|
OMCL | Hot Stocks16:01 EDT Omnicell names Nchacha Etta CFO - Omnicell announced that Nchacha E. Etta has been appointed Executive Vice President and Chief Financial Officer of the Company, effective June 1, 2023. Mr. Etta succeeds Peter J. Kuipers, who, as previously announced, will be stepping down from his role as Executive Vice President and Chief Financial Officer. Mr. Kuipers will remain with the Company through July 1, 2023, to help ensure a smooth transition of responsibilities. "We are very pleased to welcome Nchacha to the Omnicell team and we look forward to benefiting from his finance and accounting expertise as well as the broader leadership experience he brings to our organization," said Randall Lipps, chairman, president, chief executive officer, and founder of Omnicell. "Nchacha is a commercially focused and collaborative leader who not only has a proven track record of delivering strong financial and operating results but also shares our passion for improving patients' health. We believe his skillsets and insights will be incredibly valuable as we continue to focus on realizing the benefits of our recent acquisitions, strengthening our operational efficiencies and building on the momentum underway. I look forward to working closely with him as we continue to strive to deliver value for our stockholders, our employees, our healthcare partners and their patients."
|
SIEN | Hot Stocks15:54 EDT Sientra Portfinder tissue expander judged 'Substantially Equivalent' by FDA - The Sientra Portfinder tissue expander was judged to be "Substantially Equivalent" by the FDA, according to a 510(k) Premarket Notification posted to the agency's website. Reference Link
|
PNM | Hot Stocks15:49 EDT PNM Resources trading resumes
|
AGR | Hot Stocks15:45 EDT Avangrid trading resumes
|
COIN | Hot Stocks15:41 EDT Coinbase says aware of issues trading on Coinbase.com - Coinbase Support tweeted: "We are aware that some customers are having issues trading on http://Coinbase.com with Simple and Advanced trade. We are actively working on the issue and will post an update soon." Reference Link
|
PNM AGR | Hot Stocks15:21 EDT PNM says New Mexico Supreme Court denies motion to remand merger appeal - The New Mexico Supreme Court issued a decision to deny a joint motion filed by PNM Resources (PNM), Avangrid (AGR) and the New Mexico Public Regulation Commission, or NMPRC, to dismiss the appeal of its merger denial and remand the case back to the NMPRC, PNM announced. "The appeal of the NMPRC's merger denial remains in the jurisdiction of the Court, and the Court has scheduled oral arguments for September 12, 2023. There is no statutory deadline for the Court's decision. The Court also denied motions by intervening parties to supplement the record," PNM stated in press release announcing the court's decision.
|
ILMN IEP | Hot Stocks15:21 EDT Icahn says Illumina shareholders 'clearly want more change' - Icahn Enterprises' (IEP) Carl Icahn issued an open letter to the shareholders of Illumina (ILMN), saying it is "highly unusual" but "absolutely warranted" that proxy advisory services recommend removing a sitting chairman and CEO. "We note that the market reaction to the two recommendations differed substantially," the letter reads. "When Glass Lewis recommended the removal of both Chairman John Thompson and incumbent CEO Francis deSouza, Illumina's share price traded up 8% on the day. Contrast that to Illumina's share price dropping as much as 3% today after ISS' recommendation to remove just Chairman John Thompson. That indicates to us that shareholders clearly want more change! We would also remind shareholders that when our engagement was first made public, Illumina's share price increased 17% on the day. Although we believe that ISS should have endorsed more of our nominees, we believe ISS understands the need for change given the following detailed quotes in its report. The unquantified nature of the potential upside of retaining GRAIL, the continuing expense of the status quo, the longstanding relationship between the CEO and Chairman, and questions about insufficient management accountability lead to a conclusion that the dissident has made a case that change is warranted to enhance the shareholder representation in the boardroom and bolster the board's credibility... "Unfortunately, the board's credibility with shareholders has been undercut by management compensation that is not aligned with performance and a longstanding relationship between the CEO and Chairman, which taken together imply that the board has a problem holding management accountable. It is imperative to add unquestionable independence from management to the board as a quick path to bolster the board's credibility. We encourage all shareholders to think about the numerous questionable decisions that the incumbent board of directors, including Chairman John Thompson and CEO Francis deSouza, have promoted at our once great company. The list is extremely long but includes: (1) closing the highly questionable GRAIL transaction against explicit regulatory prohibitions; (2) directors requiring that enhanced insurance protections be purchased for them prior to making the unprecedented decision to acquire GRAIL over regulatory approval; (3) fighting two of the most powerful antitrust regulatory agencies tooth and nail; (4) failure to take appropriate steps - including retaining a truly independent investment advisor and obtaining a fairness opinion - to protect Illumina shareholders given the complex and intertwined relationship between Illumina and GRAIL; (5) rewarding the CEO with an 87% increase in compensation to $27 million despite $50 billion of value destruction; (6) declining revenue growth and profitability; and (7) an inability to admit simple truths, including that CEO Francis deSouza has a long-standing relationship with Chairman John Thompson." Reference Link
|
TSM... | Hot Stocks14:49 EDT Tiger Global buys TSMC, exits AppLovin in Q1 - Chase Coleman's Tiger Global disclosed in an SEC filing its holdings as of March 31, 2023. The fund's nine new buys during the quarter included, by size of position, TSMC (TSM), Apple (AAPL), XP Inc. (XP), Lam Research (LRCX), and Applied Materials (AMAT). Tiger exited eight holdings during the quarter, including by size of previous position AppLovin (APP), Qualtrics (XM), Warby Parker (WRBY), Joby Aviation (JOBY), and PDD Holdings (PDD). The fund increased its stake in 12 holdings, including by size of previous position Alphabet Class A (GOOGL), Microsoft (MSFT), Amazon (AMZN), Take-Two (TTWO), and Intuit (INTU). Tiger reduced its stake in 21 holdings, including by size of previous position Kanzhun (BZ), Snowflake (SNOW), SentinelOne (S), Spotify (SPOT), and Pagaya Technologies (PGY). The fund's top holdings as of March 31, in order of size, were Microsoft, Meta Platforms (META), JD.com (JD), Amazon, and Alphabet Class A.
|
AGR | Hot Stocks14:33 EDT Avangrid announces extension of collaboration with Yale - Avangrid announced a "meaningful contribution" to Yale University to support innovative research projects focused on advancing the clean energy transition, extending a collaboration that began in 2019 to support research into topics such as solar energy, battery storage, electric vehicles, energy policy, clean energy leadership, market development, corporate net-zero commitments, and others related to accelerating the growth of clean energy. "At Avangrid, we are convinced that innovation is key to developing the solutions that we need to advance the clean energy transition. Strong collaborations with academic institutions, like the one we have with Yale, allow different sectors to engage in meaningful dialogue and collaborate to build a cleaner, more sustainable world for generations to come," said Pedro Azagra, Avangrid CEO.
|
PNTM | Hot Stocks14:26 EDT Pontem Corp trading resumes
|
AGR | Hot Stocks14:18 EDT Avangrid trading halted, news pending
|
DNUT | Hot Stocks14:16 EDT Krispy Kreme approves transition of Joey Pruitt to U.S. CFO - Krispy Kreme said its board appointed Kelly McBride as Chief Accounting Officer. Prior to the appointment, McBride served as Vice President, Global Corporate Controller, of the company since June 2022. The board also approved the transition of Joey Pruitt from the role of the principal accounting officer of the company to the company's U.S. Chief Financial Officer.
|
PNTM | Hot Stocks14:11 EDT Pontem to redeem public shares, won't consummate initial business combination - Pontem Corporation, a special purpose acquisition company, announced that it will redeem all of its outstanding Class A ordinary shares, effective on or about the close of business on May 30, because the company will not consummate an initial business combination within the time period required by its Amended and Restated Memorandum and Articles of Association. The last day of trading will be May 26. The per-share redemption price for the public shares will be approximately $10.32. As of the close of business on May 30, the public shares will be deemed cancelled and will represent only the right to receive the redemption amount.
|
GM | Hot Stocks14:10 EDT General Motors to recall nearly 1M vehicles fitted with faulty airbag inflators - General Motors is recalling nearly 1M sports utility vehicles in the U.S. that are fitted with defective airbag inflators. The company said that 994,763 total vehicles are covered in a recalled filed with NHTSA, and includes 244,304 Model Year 2014-2017 Buick Enclave vehicles, 457,316 Model Year 2014-2017 Chevrolet Traverse vehicles, and 293,143 Model Year 2014-2017 GMC Acadia vehicles. In these vehicles, the front-driver airbag inflator may contain a supplier manufacturing defect that may result in inflator rupture during deployment. The company is "continuing its investigation" into the matter.
|
PNM | Hot Stocks14:06 EDT PNM Resources trading halted, news pending
|
NTRA NVTA | Hot Stocks13:52 EDT Jury rules in favor of Natera in patent suit against ArcherDX/Invitae - Natera (NTRA) announced that a jury in the U.S. District Court for the District of Delaware has reached a unanimous verdict in favor of Natera in the patent infringement suit it filed against ArcherDX/Invitae Corp (NVTA). The jury found that all accused ArcherDX/Invitae products infringe three of Natera's patents. The jury determined that all three patents are valid and awarded both past lost profits and a past royalty of 10%, totaling $19.35M to be paid by the defendants to Natera. At an upcoming hearing, the judge will determine whether to grant an injunction against ArcherDX/Invitae or whether to award ongoing royalties. The company stated: "We are pleased with the jury's verdict in this case, which underscores our commitment to innovative technology backed by scientific evidence that advances patient care. The Natera patents asserted against ArcherDX/Invitae in this case are a fraction of an extensive global IP portfolio of more than 360 issued or pending patents, with more than 180 in the field of oncology/MRD. We remain focused on serving the oncology community, including our many physicians and patients."
|
NTRA | Hot Stocks13:48 EDT Jury rules in favor of Natera in patent suit against ArcherDX/Invitae - Natera announced that a jury in the U.S. District Court for the District of Delaware has reached a unanimous verdict in favor of Natera in the patent infringement suit it filed against ArcherDX/Invitae Corp. The jury found that all accused ArcherDX/Invitae products infringe three of Natera's patents. The jury determined that all three patents are valid and awarded both past lost profits and a past royalty of 10%, totaling $19.35M to be paid by the defendants to Natera. At an upcoming hearing, the judge will determine whether to grant an injunction against ArcherDX/Invitae or whether to award ongoing royalties. The company stated: "We are pleased with the jury's verdict in this case, which underscores our commitment to innovative technology backed by scientific evidence that advances patient care. The Natera patents asserted against ArcherDX/Invitae in this case are a fraction of an extensive global IP portfolio of more than 360 issued or pending patents, with more than 180 in the field of oncology/MRD. We remain focused on serving the oncology community, including our many physicians and patients."
|
PNTM | Hot Stocks13:38 EDT Pontem Corp trading halted, news pending
|
CYCN | Hot Stocks13:11 EDT Cyclerion Therapeutics announces 1-for-20 reverse stock split - Cyclerion Therapeutics will effect a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-20, effective as of 5:00 p.m. Eastern Time on May 15, 2023. The reverse stock split was approved by the Company's stockholders at its annual meeting of stockholders held on May 15, 2023, with the final ratio determined by the Company's board of directors. As a result of the reverse stock split, each twenty shares of the Company's issued and outstanding common stock will be automatically combined and converted into one issued and outstanding share of common stock. The Company's shares of common stock will begin trading on a split-adjusted basis under a new CUSIP number 23255M204 on The Nasdaq Capital Market commencing upon market open on May 16, 2023 under the existing symbol "CYCN." Outstanding equity-based awards and other outstanding equity rights will be proportionately adjusted. No fractional shares will be issued as a result of the reverse stock split. Stockholders who would otherwise be entitled to a fractional share of common stock will instead receive cash in lieu of fractional shares based on $0.2232, the closing sale price of the common stock as reported in the Wall Street Journal on May 12, 2023. Immediately after the reverse stock split becomes effective, there will be approximately 2,176,244 shares of common stock issued and outstanding.
|
ZFOX | Hot Stocks13:04 EDT ZeroFox's LookingGlass expanded partnership with U.S. DoD agency - ZeroFox announced that its subsidiary, LookingGlass Cyber Solutions, has expanded its partnership with a critical U.S. Federal Department of Defense agency. This announcement comes on the heels of the recent acquisition of LookingGlass by ZeroFox. The renewal provides the agency with enhanced visibility, actionable threat intelligence, and increased protection across the entire external attack surface.
|
GREE | Hot Stocks12:55 EDT Greenidge Generation says stock to begin trading on split-adjusted basis May 16 - Greenidge Generation announced that its previously announced 1-for-10 reverse stock split of the company's Class A common stock will become effective as of 12:01 a.m. Eastern Time on May 16. The company's Class A common stock will begin trading on a split-adjusted basis on The Nasdaq Global Select Market when the markets open on May 16, under the existing trading symbol "GREE."
|
REAL | Hot Stocks12:36 EDT RealReal spikes after Burry's Scion discloses position - Shares of RealReal moved higher after Michael Burry's Scion Asset Management disclosed a position in a name. In a regulatory filing detailing its holdings as of March 31, 2023, Scion disclosed a 684,442 share position in RealReal. The stock in midday trading is up 13% to $1.26.
|
RELL | Hot Stocks12:18 EDT Richardson Electronics announces patent pending Hybrid Ultracapacitor UPS - Richardson Electronics announced new patent pending ULTRAUPS3000 Hybrid Ultracapacitor Uninterrupted Power Supply for wind turbine control systems and other industrial applications. This is the latest patent pending product adding to the company's growing portfolio of engineered solutions, the company said in a statement.
|
BAOS | Hot Stocks12:18 EDT Baosheng Media Group Holdings Ltd trading resumes
|
ROG... | Hot Stocks12:17 EDT Starboard takes stake in Rogers Corp, boosts stake in Splunk - Jeffrey Smith's Starboard Value disclosed in an SEC filing its holdings as of March 31, 2023. Starboard's five new buys during the first quarter included, by size of position, Rogers (ROG), Ritchie Bros (RBA), Israel Acquisitions (ISRL), Feutune Light Acquisition (FLFV), and Zapp Electric Vehicles (ZAPP). Starboard exited 49 positions during the quarter, including by size of previous position, Pediatrix Mecical (MD), Integrated Rail & Resources (IRRX), Fast Acquisition (FZT), and Onyx Acquisition (ONYX). Starboard increased its stake in four holdings, including by size of previous position, Splunk (SPLK), Acacia Research (ACTG), CommVault Systems (CVLT), and Humana (HUM). Starboard reduced its stake in nine holdings, including by size of previous position, Papa John's (PZZA), Aecom (ACM), LivePerson (LPSN), Willis Towers Watson (WTW), and On Semiconductor (ON). Starboard's top holdings as of March 31, in order of size, were GoDaddy (GDDY), Salesforce (CRM), Aecom, Splunk, and Willis Towers Watson.
|
LII | Hot Stocks12:16 EDT Lennox raises quarterly cash dividend to $1.10 per share - The board of directors of Lennox approved an increased quarterly cash dividend of $1.10 per share of common stock, payable July 14, 2023, to stockholders of record as of June 30, 2023.
|
NRG | Hot Stocks12:15 EDT NRG Energy 'looks forward to open dialogue' with Elliott - NRG Energy confirmed it received a letter and presentation from Elliott Associates that the fund acquired a more than 13% economic interest in the company. "NRG is committed to creating shareholder value and appreciates Elliott's interest. The Company welcomes all shareholders' input and looks forward to an open dialogue with Elliott," NRG said in a statement.
|
BAOS | Hot Stocks12:13 EDT Baosheng Media Group Holdings Ltd trading halted, volatility trading pause
|
AJG | Hot Stocks12:01 EDT Arthur J. Gallagher acquires Mavco Insurance Group, terms not disclosed - Arthur J. Gallagher & Co. announced the acquisition of Perth, Western Australia-based Mavco Insurance Group. Terms of the transaction were not disclosed. Mavco is a general insurance broker and risk management firm serving corporate clients throughout Australia and internationally. Mavco's areas of expertise include construction, health, engineering, mining and financial services. Jonathan Winter, Daniel Waters, Stephen Hughes, Rodney Aylmore and their team will relocate to Gallagher's Perth and Adelaide offices under the direction of Sarah Lyons, head of retail property/casualty brokerage operations for Gallagher in Australia.
|
FICO | Hot Stocks12:01 EDT FICO names Steve Weber as CFO - FICO announced that Steve Weber has been appointed as CFO. Weber joined FICO in 2003 and was named interim CFO in January 2023, succeeding Michael McLaughlin. FICO retained a global executive search firm and executed an extensive search before selecting Weber due to his proven track record, his deep knowledge of the FICO business, and his extensive experience as a financial leader, the company said in a statement. "Steve stepped smoothly into the CFO role and has proven to the FICO board and leadership team that he is the best person for the role in the long term," said Will Lansing, FICO's CEO. "He knows our business, our strategy and our stakeholders extremely well. We have full confidence in Steve and his leadership as we continue our growth momentum and execute our strategy."
|
LICY | Hot Stocks12:00 EDT Li-Cycle falls -8.8% - Li-Cycle is down -8.8%, or -43c to $4.50.
|
OKE | Hot Stocks12:00 EDT Oneok falls -9.6% - Oneok is down -9.6%, or -$6.09 to $57.63.
|
CGAU | Hot Stocks12:00 EDT Centerra Gold falls -13.5% - Centerra Gold is down -13.5%, or -89c to $5.72.
|
MMP | Hot Stocks12:00 EDT Magellan Midstream rises 13.4% - Magellan Midstream is up 13.4%, or $7.43 to $62.84.
|
AGS | Hot Stocks12:00 EDT PlayAGS rises 15.5% - PlayAGS is up 15.5%, or 82c to $6.12.
|
AI | Hot Stocks12:00 EDT C3.ai rises 17.5% - C3.ai is up 17.5%, or $3.39 to $22.81.
|
ZENV | Hot Stocks11:49 EDT Zenvia announces launch of chatbot tool integrated with ChatGPT - Zenvia announced the integration of ChatGPT with its chatbot tool. Luca Bazuro, CRO at Zenvia, stated, "We are constantly aligning our products to market trends by analyzing how emerging tools can optimize the solutions we offer. The customer experience allied with ChatGPT contributes to the assertiveness of the messages and opens a world of new possibilities in automatic responses, providing more fluid journeys for users, better relationships with the consumer in addition to cost efficiencies. This new development is a testament of Zenvia's commitment to innovation and dedication by delivering the most comprehensive CX SaaS platform in Latin America. The CX industry is just beginning to realize the opportunities of generative AI and we look forward to leading the pack."
|
AMZN THQQF | Hot Stocks11:39 EDT Amazon, Embracer Group enter agreement to develop The Lord of the Rings game - Amazon Games (AMZN) and Embracer Group (THQQF) announced they have reached an agreement for Amazon Games to develop and publish a new massively multiplayer online game based on The Lord of the Rings by J.R.R. Tolkien. The upcoming game will be an open-world MMO adventure in a persistent world set in Middle-earth, featuring the beloved stories of The Hobbit and The Lord of the Rings literary trilogy. The game is in early stages of production, with the Amazon Games Orange County studio-makers of the popular open-world MMO game New World-leading development. Amazon Games will publish the game globally for PC and consoles. Additional details, including launch timing, will be shared at a later date.
|
UPST | Hot Stocks11:18 EDT Castlelake agrees to buy up to $4B of consumer installment loans from Upstart - Castlelake, a global alternative investment manager, announced that Castlelake, together with a co-investor and minority partner Eltura Capital Management, has reached an agreement to purchase up to $4B of consumer installment loans from Upstart. The purchase agreement consists of the acquisition of a back book of loans and a forward flow arrangement. "Upstart is excited to collaborate with a firm that we believe is an experienced and dependable capital provider through economic cycles. Castlelake's support will help ensure we have the resources to continue scaling the deployment of our AI models and expanding access to affordable credit for all consumers," said Sanjay Datta, CFO of Upstart. "Whether through asset acquisition or bespoke private credit solutions, Castlelake has both the experience and flexibility to support companies operating in the specialty finance and consumer credit arena. With sustained consumer demand for affordable credit and the ongoing retrenchment of traditional lenders, we believe that private capital represents an increasingly important part of the financing market for companies seeking steady, secure growth," added Isaiah Toback, Partner, Deputy Co-chief Investment Officer at Castlelake.
|
BABA | Hot Stocks11:03 EDT Alibaba says SEC completed review of fiscal 2022 annual report - On May 11, the United States Securities and Exchange Commission released on its website the full set of correspondence between the SEC's Division of Corporation Finance and Alibaba from September 7, 2022 through April 12, 2023 in relation to the SEC's regular review of the company's annual report for the fiscal year ended March 31, 2022 filed on July 26, 2022. The SEC confirmed in its letter dated April 12 that it has completed its review, Alibaba said in a statement. Unless released by the SEC, correspondence between the SEC and a U.S. reporting company is not available for public review, it added.
|
NVDA... | Hot Stocks10:53 EDT Tiger Management adds Nvidia in Q1, sells out of Toast and Chevron - Julian Robertson's Tiger Management disclosed in an SEC filing its holdings as of March 31, 2023. Tiger made five new buys in the quarter, including $10.5M of Nvidia and under $300,000 worth of Martin Marietta (MLM), Sea Limited (SE) and Okta (OKTA). The firm exited four positions during the quarter: Rocket Pharmaceuticals (RCKT), Live Oak Bancshares (LOB), Toast (TOST) and Chevron (CVX). Tiger increased its holdings in four names: Pinterest (PINS), Visa (V), Delta Air Lines (DAL) and Ferrari (RACE). The firm reduced its stake in six holdings: AutoZone (AZO), Freshworks (FRSH), Nu Holdings (NU), Uber (UBER), Perimeter Solutions (PRM) and Alphabet (GOOGL). Tiger's top holdings as of March 31, in order of size, were Microsoft (MSFT), Workday (WDAY), Visa, Yext (YEXT) and MSG Sports (MSGS).
|
VNTR | Hot Stocks10:52 EDT NYSE suspends trading immediately in Venator Materials, starts delisting process - The New York Stock Exchange announced that the staff of NYSE Regulation has determined to commence proceedings to delist the ordinary shares of Venator Materials PLC - ticker symbol VNTR - from the NYSE. Trading in the company's ordinary shares will be suspended immediately. "NYSE Regulation reached its decision that the company is no longer suitable for listing pursuant to Listed Company Manual Section 802.01D after the Company's May 15, 2023 disclosure that the company has filed voluntary petitions for relief under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the Southern District of Texas. In reaching its delisting determination, NYSE Regulation noted the uncertainty as to the ultimate effect of this process on the value of the company's ordinary shares. NYSE Regulation also noted that the company's ordinary shares are proposed to be cancelled as part of the company's restructuring and will experience a complete loss on their investment based on the terms of the restructuring support agreement," the exchange stated.
|
SHASF | Hot Stocks10:50 EDT ShaMaran Petroleum appoints Garrett Soden as president, CEO - ShaMaran Petroleum announced the appointment today of Garrett Soden as President and CEO to replace Dr. Adel Chaouch effective immediately. Mr. Soden will also join ShaMaran's board of directors. He is currently President and CEO of Africa Energy Corp. and has a long history with the Lundin Group of companies. He will remain President and CEO of Africa Energy Corp. for a transition period. Chaouch has elected to step down as President and CEO of ShaMaran to focus on other endeavors as of May 15, 2023. He will not seek reelection to the Board of Directors. ShaMaran has granted incentive stock options to Mr. Soden to acquire 20,000,000 shares of the Company at an exercise price of CAD$0.065 per share. The options will have a five-year term and vest fully after two years.
|
ATVI MSFT | Hot Stocks10:40 EDT Activision up 1% to $77.94 after EU approves proposed Microsoft buyout
|
ATVI MSFT | Hot Stocks10:40 EDT European Commission approves Activision takeover by Microsoft - The European Commission has approved, under the EU Merger Regulation, the proposed acquisition of Activision Blizzard (ATVI) by Microsoft (MSFT). The approval is conditional on full compliance with the commitments offered by Microsoft. "The commitments fully address the competition concerns identified by the Commission and represent a significant improvement for cloud gaming as compared to the current situation," the agency said in a statement. The Commission said its market investigation indicated that Microsoft would not be able to harm rival consoles and rival multi-game subscription services. "At the same time, it confirmed that Microsoft could harm competition in the distribution of games via cloud game streaming services and that its position in the market for PC operating systems would be strengthened," it added. To address the competition concerns identified by the Commission in the market for the distribution of PC and console games via cloud game streaming services, Microsoft offered "comprehensive" licensing commitments, with a 10-year duration, according to the European Commission. Reference Link
|
SDIG | Hot Stocks10:38 EDT Stronghold Digital Mining announces 1-for-10 reverse stock split - Stronghold Digital Mining announced that it will effect a 1-for-10 reverse stock split of its Class A common stock, par value $0.0001 per share, and Class V common stock, par value $0.0001 per share, that will become effective on May 15, 2023, at 5:00 p.m., Eastern Time. Stronghold's Class A Common Stock will continue to trade on The Nasdaq Global Market under the symbol "SDIG" and will begin trading on a split-adjusted basis when the market opens on May 16, 2023. The new CUSIP number for the Class A Common Stock following the Reverse Split will be 86337R 202. The Reverse Split is primarily intended to increase the per share market price of the Company's Class A Common Stock and bring the Company into compliance with the minimum bid price requirement for maintaining its listing on Nasdaq. To evidence compliance with this requirement, the closing bid price of the Company's Class A Common Stock must be at least $1.00 per share for a minimum of 10 consecutive business days by May 30, 2023. The reduction in the number of issued and outstanding shares of Common Stock as a result of the Reverse Split is, absent other factors, expected to proportionately increase the market price of the Class A Common Stock to a level above the current market trading price, although there is no assurance that this will occur. Additionally, there is no assurance that the Reverse Split will allow the Company to achieve compliance with Nasdaq's listing maintenance standard.
|
ATVI... | Hot Stocks10:37 EDT Correction: European Commission approves Activision takeover by Microsoft - The previous headline including Electronic Arts (EA) has been removed.
|
TPL | Hot Stocks10:36 EDT Lion Long Term urges Texas Pacific Land stockholders to vote against Proposal 4 - Lion Long Term Partners LP, a significant Stockholder of 50,600 shares of Texas Pacific Land Corporation, issued a letter to stockholders and proxy advisors, which read, "On April 28th, following the release of the transcript of the April 17th trial hearing in Delaware Chancery Court, we wrote to Glass Lewis, Institutional Shareholder Services and Egan Jones urging them to review their recommendation to vote "For" Proposal 4 at the adjourned 2022 Texas Pacific Land Corporation Annual Meeting, to be held May 18, 2023 solely to consider Proposal 4. We also wrote to The New York Stock Exchange urging them to review their classification of Proposition 4 as "Routine". Yesterday Glass Lewis announced that it has changed its recommendation with respect to Proposal 4 to "Against" and we urge the other Proxy Advisors to review their case files and Glass Lewis' detailed explanation of its change in position and follow Glass Lewis in recommending an Against vote on Proposal 4, and we urge the Stockholders of the Company who have voted For Proposal 4 to reconsider their position. In its May 9 update of its analysis of Proposal 4, Glass Lewis explains its change of recommendation as based on its review of the documents filed in the Delaware Chancery Court litigation initiated by the Company against the "Investor Group" of the Company owning some 21% of the Company outstanding common shares, and TPL's April 25 supplemental proxy materials. Glass Lewis noted that the Investor Group submitted proxies for the 2022 Annual Meeting to vote against Proposal 4, and that at the Annual Meeting management had obtained favorable votes from only 35.2% of the outstanding common shares, well short of the simple majority required for approval of Proposal 4. Glass Lewis further noted that the position of the Investor Group is that the Company should be governed as it has for most of its 135-year history operating as a liquidating trust vehicle with no ability to issue new shares, let alone for the purpose of pursuing external acquisitions, and that, if approved, Proposal 4 would give management of the Company many billions of dollars' worth of unissued Company stock, effectively giving the Company a blank check to dilute stockholders through acquisitions with stock and equity compensation grants to management. In its highly perceptive nine paragraph analysis Glass Lewis argues strongly that Stockholders should vote against Proposal 4 and it noted that Stockholders who have previously cast votes in favor of Proposal 4 still have the ability to switch their votes to AGAINST, which Glass Lewis now advises they do. We do too."
|
WKEY | Hot Stocks10:35 EDT WISeKey extends rally, shares up 66% to $3.55 after tweet
|
EA MSFT | Hot Stocks10:34 EDT European Commission approves Electronic Arts takeover by Microsoft
|
GMVD | Hot Stocks10:26 EDT G Medical announces receipt of Nasdaq exception for continued listing - G Medical Innovations announced that, on May 11, 2023, the Company received notice from the Hearings Panel of the Nasdaq Stock Marketthat the Panel has granted the request of the Company to continue its listing on Nasdaq, subject to the conditions described below. As previously disclosed by the Company, on November 22, 2022, the Company received a deficiency letter from the Listing Qualifications Department of the Nasdaq notifying it that, based on its shareholders' deficit of $1,240 thousand as of June 30, 2022, as reported in the Company's Report of Foreign Private Issuer on Form 6-K on November 18, 2022, the Company was no longer in compliance with the minimum shareholders' equity requirement for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(1), which requires listed companies to maintain shareholders' equity of at least $2.5 million. The Company had 45 calendar days, or until January 6, 2023, to submit a plan to regain compliance. The Company submitted its compliance plan on January 6, 2023 and made a subsequent submission on January 19, 2023. On February 16, 2023, the Company received a letter from the Staff of Nasdaq notifying that Nasdaq had determined to delist the Company's Ordinary Shares and tradeable warrants from Nasdaq based on (i) non-compliance with the minimum $2,500,000 stockholders' equity requirement for continued listing set forth in Nasdaq Listing Rule 5550(b) and providing the Staff a submission of information that contained material misrepresentations, in violation of Nasdaq Listing Rule 5250(a)(1), in relation to the Company's extraordinary general meeting of shareholders, which was adjourned on February 9, 2023 and ultimately held and concluded on February 16, 2023. On February 23, 2023, the Company requested a hearing before the Panel, which stayed any delisting or suspension action pending the hearing and the expiration of any additional extension period granted by the Panel following the hearing. On May 11, 2023, the Panel granted the Company's request to continue its listing on Nasdaq subject to the requirement that, by no later than August 4, 2023, it provide the Panel with unaudited interim financial statements for the second quarter of 2023 and demonstrate to the Panel that the Company continues to meet the equity requirement. Upon review of the Company's interim financial statements for the second quarter of 2023, the Panel will decide if the Company has demonstrated an ability to maintain compliance with the continued listing requirements on a long-term basis. In addition, from May 11, 2023 until the end of the Exception Period, the Panel reserves the right to reconsider the terms of this exception based on any event, condition or circumstance that exists or develops that would, in the opinion of the Panel, make continued listing of the Company's securities on Nasdaq inadvisable or unwarranted. Until the end of the Exception Period, the Company is required to provide prompt notification to the Panel of any significant events that may affect the Company's compliance with Nasdaq requirements. Finally, the Panel has informed the Company that it does not believe the Company engaged in material misrepresentations to the Nasdaq Staff in relation to the Company's extraordinary general meeting of shareholders, which was adjourned on February 9, 2023 and ultimately held and concluded on February 16, 2023.
|
WKEY | Hot Stocks10:21 EDT WISeKey jumps after tweet about satellite talks with Elon Musk - Shares of WISeKey jumped after the company tweeted, "Discussion in Paris @choosefrance between @WISeKey CEO @CreusMoreira with @elonmusk on how to launch more low orbit http://Wisesat.space Picco satellites using #SpaceX and increment the 13 wise.sat fossa satellites we have already in orbit." Shares of WISeKey jumped 37% to $2.97 before being halted for volatility. Reference Link
|
EHC... | Hot Stocks10:18 EDT Jana exited Encompass Health during Q1, bought more FIS - Barry Rosenstein's Jana Partners disclosed in an SEC filing its holdings as of March 31, 2023. Jana firm exited one position during the quarter, selling 387,062 shares of Encompass Health (EHC). The fund increased its stake in two holdings: SPDR S&P 500 ETF Trust (SPY) and FIS (FIS). Jane reduced its stake in four holdings: Mercury Systems (MRCY), Labcorp (LH), Enhabit (EHAB) and Freshpet (FRPT). Jana's top holdings as of March 31, in order of size, were Freshpet, New Relic (NEWR), TreeHouse Foods (THS), FIS and Labcorp.
|
APD | Hot Stocks10:17 EDT Aers Energy Belgie selects Air Products to build hydrogen refueling station - Air Products signed an agreement with Aers Energy Belgie to develop a multi-fuel, hydrogen refueling station for trucks. It will be located on a concession in the port of Zeebrugge, which Aers Energy Belgie has been awarded. Within this location, Aers will also operate a new secure truck stop, rest area, convenience store and restaurant. The new station will be the first commercial-scale hydrogen refueling station in Europe with liquid hydrogen storage. It will be built and operated by Air Products in addition to other liquid hydrogen refueling stations the company is developing throughout Europe. The project itself, is part of a wider strategy to support Belgium and Europe's sustainable development and ambition towards CO2-free heavy-duty road transport.
|
ACHC MET | Hot Stocks10:16 EDT Acadia Healthcare appoints Judith Scimone as CHRO - Acadia Healthcare Company (ACHC) announced that Judith Scimone has joined Acadia as the Company's Chief Human Resources Officer. In this role, she will shape and advance the Company's people strategy, helping to solidify Acadia's position as the premier employer of choice within the behavioral healthcare industry. As a new member of the Company's executive leadership team, Scimone will report to Chris Hunter, CEO Scimone joins Acadia from MetLife (MET), where she served as Senior Vice President, Human Resources for U.S Business & Global Functions.
|
BSET | Hot Stocks10:04 EDT Bassett Furniture signs contract with Acuative - Bassett Furniture Industries signed a contract with Acuative to support its growing need for networking communications and security technology. Acuative will update all Bassett stores with an array of networking equipment and communications tools. To support this new technology, Acuative will provide real-time technical support and simultaneously upgrade the backup wireless network connectivity at each location. Acuative provides networking and communications as a service via a subscription model to a number of major retail and manufacturing customers and sees the Bassett relationship as a collaborative fit. This partnership will ensure every store provides fast, wall-to-wall wireless network coverage for both employees and customers.
|
OKE | Hot Stocks10:00 EDT Oneok falls -9.8% - Oneok is down -9.8%, or -$6.26 to $57.46.
|
AZUL | Hot Stocks10:00 EDT Azul falls -10.0% - Azul is down -10.0%, or -78c to $7.00.
|
CGAU | Hot Stocks10:00 EDT Centerra Gold falls -11.8% - Centerra Gold is down -11.8%, or -78c to $5.83.
|
SMRT | Hot Stocks10:00 EDT SmartRent rises 11.2% - SmartRent is up 11.2%, or 37c to $3.68.
|
AGS | Hot Stocks10:00 EDT PlayAGS rises 12.3% - PlayAGS is up 12.3%, or 65c to $5.95.
|
MMP | Hot Stocks10:00 EDT Magellan Midstream rises 13.1% - Magellan Midstream is up 13.1%, or $7.28 to $62.69.
|
BFRI | Hot Stocks09:56 EDT Biofrontera Inc. granted new patent related to photodynamic therapy protocol - Biofrontera announces that the U.S. Patent and Trademark Office has granted a new patent to Biofrontera Bioscience GmbH related to a photodynamic therapy protocol that is expected to be less painful but similarly effective to conventional PDT. This new patent is exclusively licensed to Biofrontera and expires in April 2039, including a patent term adjustment approved by the USPTO. Titled "Photodynamic therapy comprising two light exposures at different wavelengths" (U.S. Patent No. 11,642,411 B2), the patent covers the use of a composition comprising a photosensitizer, a light-sensitive molecule activated by the absorption of light, that is used in PDT performed with illumination by two different photo-activating wavelengths of light.
|
LICY | Hot Stocks09:47 EDT Li-Cycle falls -5.7% - Li-Cycle is down -5.7%, or -28c to $4.66.
|
CGAU | Hot Stocks09:47 EDT Centerra Gold falls -7.1% - Centerra Gold is down -7.1%, or -47c to $6.14.
|
OKE | Hot Stocks09:47 EDT Oneok falls -8.2% - Oneok is down -8.2%, or -$5.23 to $58.49.
|
XYF | Hot Stocks09:47 EDT X Financial rises 6.5% - X Financial is up 6.5%, or 22c to $3.60.
|
SD | Hot Stocks09:47 EDT SandRidge Energy rises 7.6% - SandRidge Energy is up 7.6%, or $1.13 to $15.97.
|
MMP | Hot Stocks09:47 EDT Magellan Midstream rises 14.4% - Magellan Midstream is up 14.4%, or $7.99 to $63.40.
|
OMH | Hot Stocks09:43 EDT Ohmyhome Ltd trading resumes
|
GSIT | Hot Stocks09:43 EDT GSI Technology trading resumes
|
HCDI | Hot Stocks09:42 EDT Harbor Custom Development Inc trading resumes
|
OMH | Hot Stocks09:38 EDT Ohmyhome Ltd trading halted, volatility trading pause
|
DUNE HGAS | Hot Stocks09:38 EDT Global Hydrogen Energy enters business combination deal with Dune Acquisition - Global Hydrogen Energy and Dune Acquisition Corporation announced that they have entered into a definitive agreement for a business combination, which would result in Global Hydrogen becoming a publicly listed company. The combined company will be called Global Gas Corporation upon the closing of the business combination and its common stock is expected to be listed on Nasdaq under the new ticker symbol "HGAS". Headquartered in New York, Global Hydrogen is led by Founder and Chief Executive Officer William B. Nance, who has over a decade of hydrogen and industrial gas experience. Global Hydrogen is a 100% minority-owned business that targets both private and publicly-funded hydrogen development and carbon recovery projects, including projects supported by local, county, state, and national- level governments. Global Hydrogen primarily targets renewable waste as feedstock to generate the industrial gases it sells, and seeks arrangements with owners of wastewater treatment plants, food waste processing facilities, agricultural farms, and landfills as well as producers and distributors of renewable natural gas.Under the terms of the Unit Purchase Agreement, Dune will complete a business combination with Global Hydrogen at a pro forma combined enterprise value of approximately $112 million. The Board of Directors of Dune has received an independent fairness opinion. The Board of Directors of Dune and the managers and unitholders of Global Hydrogen have each unanimously approved the proposed business combination, which is expected to close in the second half of 2023 and remains subject to approval by Dune's stockholders and customary closing conditions. Mr. Nance, who is also a director of Dune, was recused from, and did not participate in, the consideration or approval of the proposed business combination by the Dune Board of Directors.
|
KSCP | Hot Stocks09:35 EDT Knightscope awarded $1.25M contract for K1 Blue Light Towers, K1 E-Phones - Knightscope announced that it received a $1.25M contract for its K1 Blue Light Towers and K1 E-Phones. Rutgers, The State University of New Jersey, signed purchase orders for 145 devices in total.
|
ATMC | Hot Stocks09:35 EDT Alphatime Acquisition Corp trading resumes
|
GSIT | Hot Stocks09:33 EDT GSI Technology trading halted, volatility trading pause
|
HCDI | Hot Stocks09:32 EDT Harbor Custom Development Inc trading halted, volatility trading pause
|
DSX | Hot Stocks09:31 EDT Diana Shipping announces time charter contract for m/v Medusa - Diana Shipping announced that, through a separate wholly-owned subsidiary, it has entered into a time charter contract with ASL Bulk Shipping Limited for one of its Kamsarmax dry bulk vessels, the m/v Medusa. The gross charter rate is US$14,250 per day, minus a 5% commission paid to third parties, for a period until minimum February 10, 2025 up to maximum April 15, 2025. The charter commenced yesterday. The "Medusa" is a 82,194 dwt Kamsarmax dry bulk vessel built in 2010. The employment of "Medusa" is anticipated to generate approximately US$8.92 million of gross revenue for the minimum scheduled period of the time charter.
|
EMOTF | Hot Stocks09:30 EDT Emerita Resources announces additional results from La Infanta deposit - Emerita Resources announces assay results from 21 additional holes from the 2023 delineation drilling at La Infanta deposit, part of Emerita's wholly owned Iberian Belt West project. These results will be included in the upcoming NI 43-101 compliant mineral resource estimate which is presently being finalized and is expected to be released later this week. IBW hosts three previously identified massive sulphide deposits: La Infanta, La Romanera and El Cura. All deposits are open for expansion along strike and at depth. Joaquin Merino, P.Geo., President of Emerita stated, "The continued high-grade results at La Infanta are very encouraging and support our decision to expand our exploration footprint at the IBW project. The Emerita team is planning additional drilling to continue exploration beyond the upcoming MRE. The holes in this release are being incorporated into the block model for the forthcoming MRE. The Independent Qualified Person is in the final stages completing the independent mineral resource estimate."
|
ATMC | Hot Stocks09:30 EDT Alphatime Acquisition Corp trading halted, volatility trading pause
|
LVO | Hot Stocks09:29 EDT LiveOne partners with OTT Studio as multi-year exclusive streaming provider - LiveOne announced an exclusive content distribution deal with OTT Studio, a leading streaming technology platform and CTV app publisher. LiveOne will be OTT Studio's exclusive music streaming provider, delivering LiveOne's 600 expertly curated radio stations via OTT's new Music Plus application. The deal will expand the distribution of LiveOne's premium audio and entertainment content to an additional 47 million CTVs in North America via LG's webOS and Vizio's SmartCast platforms. Patrick Markel, LiveOne's Senior Director of Business Development and Strategic Partnerships, said, "We're excited to execute this multi-year agreement with OTT Studio to make LiveOne even more accessible to music lovers by leaning into OTT Studio's unique ability to reach millions of customers on the most popular streaming TV devices." The Music Plus app is slated to launch in Q3 2023 on Roku and FireTV, and on LG's webOS, Vizio's SmartCast and other platforms later in the year.
|
GRCL | Hot Stocks09:28 EDT Gracell to host KOL webinar on Multiple Myeloma - Gracell Biotechnologies announced that it will host a key opinion leader webinar on May 22, 2023 at 9:00 am ET. Gracell Biotechnologies' KOL event will feature participation from management and key opinion leader Saad Usmani, MD, MBA, FACP, Myeloma & Cellular Therapy Specialist, Chief of Myeloma Service at Memorial Sloan Kettering Cancer Center. The discussion will focus on the treatment landscape for multiple myeloma and highlight the unmet clinical needs in the U.S. A live question and answer session will follow the formal presentation.
|
SEV | Hot Stocks09:27 EDT Sono applies for self-administration proceedings under German Insolvency Acy - On May 15, 2023, Sono Group N.V. applied to the insolvency court of Munich, Germany, to permit the opening of a self-administration proceeding with respect to Sono Group N.V. pursuant to Section 270 (b) of the German Insolvency Code. On the same day, Sono Motors GmbH, Sono Group N.V.'s sole wholly-owned subsidiary, applied to the same court to permit the opening of self-administration proceeding in the form of a protective shield proceeding with respect to Sono Motors GmbH pursuant Section 270 (d) of the German Insolvency Code. Sono Group N.V. conducts its business through its subsidiary Sono Motors GmbH, and the terms "we" and "our" used herein refer to Sono Group N.V. together with its subsidiary Sono Motors GmbH. At the end of February 2023, we announced our decision to restructure our business model to focus exclusively on retrofitting and integrating solar technology into third-party vehicles going forward. At the same time, we discontinued our Sion passenger car program with immediate effect and terminated approximately 250 employees. A repayment plan was developed to handle customer claims arising from the Sion reservations. We continued to face challenges to obtain external financing and to date have not been successful in selling our Sion passenger car project and related assets. After other financing options failed to materialize, our management ultimately concluded that Sono Motors GmbH is over-indebted and faces impending illiquidity, with Sono Group N.V., in turn, becoming over-indebted and also facing impending illiquidity. As a consequence, management decided to apply for the opening of self-administration proceedings with respect to Sono Group N.V. and Sono Motors GmbH with the goal of sustainably restructuring our business. Self-administration proceedings are debtor-in-possession type proceedings under German insolvency law, which are available to businesses in financial distress and typically aim to preserve the business and the entity that are the subject of the proceedings. In these proceedings, management retains control and operation of the subject company's business under the supervision of a custodian, who is initially appointed on a preliminary basis. We understand that in the German market a self-administration proceeding in the form of a protective shield proceeding, such as the one which Sono Motors GmbH has applied for, is perceived by suppliers, customers, and potential investors as a proceeding with improved chances for a successful in-court business restructuring. We believe that this perception may improve our chances of sustainably restructuring, recapitalizing, and realigning Sono Motor GmbH's business in the interest of its creditors, suppliers, customers, and employees. In order to be able to apply for a self-administration proceeding in the form of a protective shield proceedings, Sono Motors GmbH was required to provide a third-party attestation that the company is not illiquid and that the intended restructuring does not manifestly lack the prospect of success. Following the filing of their respective applications, Sono Group N.V. and Sono Motors GmbH are generally prohibited from repaying any pre-application debt. Furthermore, if and when the self-administration proceedings are admitted by the court on a preliminary basis, creditors will be prohibited from foreclosing against the companies on any claims they may have. In addition, subject to certain limited exceptions, Sono Group N.V. will lose control of its sole subsidiary Sono Motors GmbH. We are in the process of analyzing the potential accounting and financial reporting implications of the applications for self-administration proceedings, including with respect to the ability of Sono Group N.V. to continue to consolidate Sono Motors GmbH while such proceedings are ongoing. With the help of external advisors, Sono Group N.V. and Sono Motors GmbH are in the process of each preparing a draft restructuring plan to be submitted to the court for approval by the respective company's creditors and for confirmation by the court in the context of the respective proceeding. The draft restructuring plans will in each case set out how the respective company intends to restructure its debt and to procure the inflow of new money.Even if the openings of the respective proceedings are permitted by the court, the successful conclusion of the respective proceedings and Sono Group N.V.'s and Sono Motors GmbH's exits from the respective proceedings remain subject to a number of contingencies and risks, including, but not limited to, whether the companies are able to identify and successfully access sufficient sources of liquidity to enable a restructuring, whether creditors in each case approve the respective restructuring plan with the required majorities, and whether the court confirms the restructuring plan in each case. Should the self-administration proceedings applied for by Sono Group N.V. and Sono Motors GmbH, respectively, not be approved or should the respective draft restructuring plan fail to be approved by the respective company's creditors or confirmed by the court, the respective company would become subject to regular insolvency proceedings, which could involve its liquidation.
|
WIT | Hot Stocks09:27 EDT Wipro partners with Google to accelerate clients' cloud adoption - Wipro Limited (WIT) announced that its FullStride Cloud Studio has partnered with Google (GOOG,GOOGL) Cloud's Rapid Migration Program or RaMP, to help clients accelerate their journey to the cloud and pursue a migration strategy anchored in business outcomes. Wipro will integrate its proven framework, together with artificial intelligence and automated tooling, into RaMP, which will help clients increase efficiency, agility, and time to market. Leveraging Wipro FullStride Cloud Studio's industrialized 'as-a-service' model, the partnership will deliver faster returns on cloud investments. Wipro FullStride Cloud Studio has a track record of helping clients achieve up to 5X faster Cloud adoption at 30% lower cost, 90% automated post migration activities, and 3X faster business acceptance. This partnership with Google builds on Wipro's existing collaboration with Google and Google Cloud Professional Services Organization and aims to deepen the value delivered to joint clients.
|
GOVX | Hot Stocks09:27 EDT GeoVax Labs to present vaccine data at upcoming scientific meetings - GeoVax Labs announced that it will be represented during two upcoming scientific meetings, including Vaccines Summit Boston 2023 in Boston, MA, May 22-24, 2023 and CYTO 2023 in Montreal, Quebec, Canada, May 20-24, 2023. Don Diamond, Ph.D., Professor, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, will deliver a presentation titled, "Assessment of GEO-CM04S1 for Prevention of COVID-19 in Immunocompromised Cell Therapy Patients; An Open-Label Safety Study." Dr. Diamond's presentation will include a description of the development and clinical testing of GeoVax's vaccine candidate, GEO-CM04S1. CM04S1 is a next-generation COVID-19 vaccine based on the use of the MVA viral vector platform, which presents multiple antigens to the immune system to induce both antibody and T cell responses. The vaccine is designed to provide durable protection against new and continually emerging variants of COVID-19, limiting the need for frequent modification and updating. GeoVax is focusing on the clinical development of this vaccine for use in patients with impaired ability to mount adequate protective immune responses to currently available COVID-19 vaccines, to include those with certain malignancies and autoimmune disorders, cell and organ transplant patients, individuals with end-stage kidney disease receiving hemodialysis, and potentially elderly individuals who respond poorly to other vaccines. These individuals may not be able to raise or maintain protective antibody responses following receipt of first-generation mRNA vaccines, contributing to reduced vaccine efficacy. On Tuesday, May 23, Sandra Ortega-Francisco, Ph.D., Department of Hematology and Hematopoietic Cell Transplantation and Hematologic Malignancies Research Institute, City of Hope, will participate in a poster presentation titled, "Induction of multi-antigen specific T cell responses by a synthetic MVA-SARS-CoV-2 vaccine in patients with hematological malignancies."
|
PRST | Hot Stocks09:24 EDT Presto Automation moves Q3 earnings call to May 18 - Presto Automation announced it will release its financial results for the fiscal third quarter 2023 results on Thursday, May 18, 2023 after the financial markets close versus the previously announced date of May 15, 2023 . Presto is revising the date of its earnings press release and conference call for reasons related to the time required to complete quarterly review procedures.
|
ZVSA | Hot Stocks09:22 EDT ZyVersa announces article published on Cholesterol Efflux Mediator VAR 200 - ZyVersa Therapeutics announces publication of an article in the peer-reviewed journal, Metabolism, which supports the mechanism of action of Cholesterol Efflux Mediator VAR 200 in development to treat kidney diseases. In the paper titled, "ABCA1 deficiency-mediated glomerular cholesterol accumulation exacerbates glomerular endothelial injury and dysfunction in diabetic kidney disease," the authors reported that ABCA1 deficiency contributes to injury and dysfunction of the kidney's filtration system in early diabetic kidney disease. They proposed that ABCA1 transporter deficiency results in glomerular cholesterol/lipid accumulation leading to inflammation and cell death. This causes structural and functional damage to the kidney's filtration system and in turn, protein spillage into the urine and DKD progression. "The research published in Metabolism demonstrating that deposition of glomerular cholesterol contributes to structural damage and dysfunction of the kidney's filtration system in models of type 2 diabetes is consistent with data from VAR 200's preclinical program. Our preclinical program showed similar results not only in models of DKD, but also in models of two orphan kidney diseases, focal segmental glomerular sclerosis and Alport Syndrome. More importantly, by mediating cholesterol transport out of the glomeruli through passive transport and upregulation of ABCA1 transporters, VAR 200 protected against glomerular injury and fibrosis, and significantly reduced protein spillage into the urine in all three kidney diseases," commented Stephen Glover, ZyVersa's Co-founder, Chairman, CEO and President. "Given the unmet needs for effective treatments for kidney disease, we are hopeful that VAR 200 will demonstrate similar results in patients with kidney disease in studies planned to initiate late this year," continued Glover.
|
TLS | Hot Stocks09:20 EDT Lp Resilient Services JV awarded STTR Phase II contract from U.S. Air Force - Lp Resilient Services JV announces it has been awarded a Small Business Technology Transfer, STTR, Phase II contract by the United States Air Force AFWERX program. This new contract is focused on developing a prototype Supply Chain Risk Management solution and investigating its potential to fill capability gaps in the Department of the Air Force. This effort is being accomplished in cooperation with the Penn State Applied Research Laboratory and Telos Corporation to deliver a custom solution using Xacta, a software-as-a-service offering that enables enterprise-wide visibility of supply chain notifications for Department of Defense program offices. "We are excited to be a part of this digital transformation effort with the potential to reduce the organizational attack surface of our key customers through more secure supply chains," said John B. Wood, CEO and chairman, Telos. "With our strategic partners at the Penn State ARL and LpRS, we plan to deliver a solution to make it easier for organizations to plan for their business expansion, develop new programs in service to the public, and prepare our warfighters for the nation's defense."
|
ALPP | Hot Stocks09:18 EDT Alpine 4 Holdings' Alternative Laboratories reports backlog of $8M - Alpine 4 Holdings announces that its subsidiary, Alternative Laboratories' backlog increased to $8 Million in Q1 2023. This record setting back log represents its highest level since the purchase of Alternative Labs by Alpine 4 Holdings. The Company also saw growth of 10% on its Q1 2023 revenue as compared to Q1 2022.
|
AGRI | Hot Stocks09:18 EDT AgriFORCE Growing Systems engages TerraProtein to provide advisory services - AgriFORCE Growing Systems announced that it has engaged TerraProtein Equity Partners B.V., a premier advisory firm focused on the food and agricultural industry, to support the planned acquisitions in progress. Ingo Mueller, CEO of AgriFORCE, said, "We are making continued progress in the due diligence of our M&A activities, which will allow us to expand our offerings to customers. TerraProtein bring a highly focused skillset in advancing and helping complete transactions, which we believe will be invaluable in helping us achieve our goals and ensure a successful completion of our acquisitions in progress."
|
AFIB | Hot Stocks09:17 EDT Acutus Medical to showcase cardiac mapping, ablation technologies at HRS 2023 - Acutus Medical announces its participation in the upcoming Heart Rhythm Society, HRS, Annual Scientific Sessions in New Orleans, LA from May 19-21, 2023. As an exhibitor at HRS, Acutus Medical will showcase its latest groundbreaking electrophysiology systems and technologies, including AcQMap, the industry's only whole-chamber, single-beat, non-contact mapping system. Designed to help physicians advance the standard of care for patients with complex arrhythmias, AcQMap equips electrophysiologists with an unprecedented ability to map what was historically unmappable. "We are pleased to join HRS '23 to offer the industry an opportunity to engage directly with our state-of-the-art cardiac mapping and ablation therapy technologies, as well as meet with many of our key physician partners," said David Roman, President & CEO of Acutus Medical. "The recently published RECOVER AF study is driving important discussions around the pivotal advantage AcQMap(R) offers physicians in the retreatment of AF. HRS provides an ideal forum to provide deeper insight into the study's findings and further demonstrate AcQMap's significant clinical benefits."
|
HEI | Hot Stocks09:16 EDT Heico to acquire Wencor Group for $1.9B in cash, $150M in Class A common stock - HEICO Corporation entered into an agreement to acquire Wencor Group from affiliates of Warburg Pincus LLC and Wencor's management for $1.9 billion in cash and $150 million in HEICO Class A Common Stock1 to be paid at closing, or $2.05 billion in the aggregate. The transaction will be HEICO's largest ever in purchase price, as well as revenues and income acquired. Wencor will become part of HEICO's Flight Support Group. HEICO stated that it expects the highly synergistic acquisition to be accretive to its earnings within the year following the closing. Further, HEICO anticipates it will continue to achieve its often-articulated growth objectives in the years following the closing. Founded in 1955, Wencor is a large commercial and military aircraft aftermarket company offering factory-new FAA-approved aircraft replacement parts, value-added distribution of high-use commercial & military aftermarket parts and aircraft & engine accessory component repair and overhaul services. Wencor is based in Peachtree City, GA and provides its parts and services internationally, employing approximately 1,000 team members in 19 facilities around the United States. HEICO currently employs approximately 9,000 Team Members at over 100 facilities worldwide. Wencor's customers include airlines worldwide, aircraft maintenance repair and overhaul companies, military agencies and defense contractors. Wencor's parts and repairs are found in hydraulic, pneumatic, electronic and electro-mechanical, cockpit and galley systems throughout numerous aircraft models and provide Wencor's customers with significant cost savings. HEICO anticipates that Wencor will generate approximately $724 million and $153 million in adjusted proforma revenues and EBITDA, respectively, in calendar year 2023.2 Further, HEICO expects to receive estimated tax benefits of approximately $75 million that will be realized through fiscal year 2038. Including the estimated tax benefits and without accounting for any expected synergies, HEICO anticipates that its effective purchase price multiple will be approximately 12.9 times Wencor's projected proforma adjusted EBITDA. Following the acquisition's completion, HEICO anticipates its net debt-to-EBITDA leverage ratio will be below 3:1 and will return to its historical levels within roughly a year to eighteen months after the acquisition, before taking into account future acquisitions and other possible capital deployment activities. HEICO stated that it believes its Flight Support Group will achieve meaningful synergies from the acquisition, though it is not now providing details on those likely synergies. HEICO's Flight Support Group has successfully achieved significant financial and other synergies from acquisitions of other businesses over many years. Closing is subject to customary closing conditions, including, among other things, antitrust clearance. The parties anticipate closing the transaction by the end of calendar 2023.
|
CNSP | Hot Stocks09:14 EDT CNS Pharmaceuticals expects cash to fund operations into 4Q23 - The Company's current expectation is that the cash on hand, including the issuances subsequent to the first quarter, is sufficient to fund operations beyond the interim analysis and into the fourth quarter of 2023.
|
CALX | Hot Stocks09:13 EDT Calix extends existing $100M share buyback program - On May 11, Calix's board approved an amendment of its $100M stock repurchase program, previously approved on July 15, 2022, to eliminate the end date of July 15, 2023. The program will now continue until the repurchase program is suspended or discontinued. As of today, Calix has repurchased $10M of Calix's common stock at an average price of $44.53 per share.
|
AWH | Hot Stocks09:13 EDT FMW Media's New to The Street will feature Aspira Women's Health - FMW Media Works' New to The Street will feature and broadcast Aspira Women's Health on its nationwide television media platforms. Jane King, New to The Street's TV Host will interview AWH's CEO Nicole Sandford, and together create a new segment on the show which focuses on women's health issues. The first filming with AWH occurred on World Ovarian Cancer Day, May 8, 2023. In this segment, Jane and Nicole talk about AWH's history as a leading innovator of advanced diagnostic solutions to improve health outcomes for women facing ovarian cancer and other gynecologic disease. Nicole states, "Ovarian cancer is the deadliest gynecological cancer. Most ovarian cancers are found in stage three or four when there is a very low chance of survival. A lack of effective diagnostic tools often leads women to make important decisions based on fear instead of facts. I look forward to explaining the important role our non-invasive tests play in supporting better care, and to working with Jane to address women's healthcare needs and concerns."
|
WISA | Hot Stocks09:12 EDT WiSA Technologies to acquire Comhear in exchange for stock, sees accretion - "WiSA Technologies has signed a non-binding letter of intent to acquire Comhear a developer of AI-enabled adaptive audio technology. The transaction is expected to close in the third quarter of 2023 and be accretive in the fourth quarter of 2023. "The synergy between the two companies is compelling on many levels, with similar business models driven by audio IP, licensing and module sales," said Brett Moyer, CEO of WiSA. "We are targeting many of the same customers yet offer complementary solutions that address different use cases, providing WiSA's sales team with more products to sell to our customers. We are both poised to penetrate the audio market through licensing our technologies. The acquisition of Comhear enhances WiSA's position as a leader in immersive wireless audio technology, and we expect that the combined company will be well positioned to take market share in this growing market." "We expect the addition of Comhear to be accretive beginning in Q4 2023. As a result, we are guiding for full year 2024 revenue in the range of $10M to $15M," added Moyer. Under the proposed acquisition, WiSA would acquire all shares of Comhear common stock in exchange for newly issued shares of WiSA common stock. The board of directors of the combined company is expected to consist of seven members, four of whom will be appointed by WiSA, including Mr. Moyer, and three of whom will be appointed by Comhear, including Mr. Arno as chairman. The company expects to issue a proxy statement seeking shareholder approval for the proposed transaction in July 2023. However, there can be no assurance that the parties will successfully negotiate and enter into definitive agreements regarding the proposed transaction, or that the proposed transaction will be completed as currently contemplated, or at all.
|
EMR | Hot Stocks09:11 EDT Emerson Electric chosen by Syzygy Plasmonics to automate electrical reactor - Emerson has been chosen by Syzygy Plasmonics to automate its catalyst reactor technology that uses light instead of thermal energy, such as heat generated from burning fossil fuels, for chemical manufacturing. The all-electric production method is designed to replace fossil fuel-based combustion. Syzygy estimates its reactor systems could eliminate 1 gigaton of CO2 emissions by 2040. For the Syzygy modular reactors, Emerson will provide hardware, software and services, including its DeltaV distributed control system, industrial software for process simulation and data analytics; Rosemount instrumentation to measure pressure, temperature, level and flow; and Fisher valves to control pressure and improve safety. Syzygy has three field trials planned for 2023.
|
TBIO | Hot Stocks09:11 EDT Translate Bio to present at PEGS Boston 2023 - Telesis Bio announced they will be showcasing their benchtop automation solutions for DNA and mRNA synthesis at Protein Engineering Summit, PEGS Boston 2023, which begins today in Boston, Massachusetts. Daniel Gibson, Ph.D., CTO and Co-founder of Telesis Bio and the Telesis Bio team will be discussing Telesis Bio's transformative solutions for addressing synthesis bottlenecks in discovery workflows and enabling rapid candidate screening and evaluation. Telesis Bio will present in two sessions; Jyotsna Venugopal, Ph.D., Director of Product Marketing, will present "Automated solutions for overcoming synthesis bottlenecks in CAR-T cell therapy workflows" on Tuesday, May 16, and Ankita Das, Ph.D., Senior Product Manager, will present "Sequence in, mRNA out. A new paradigm to accelerate discovery of mRNA vaccines and therapeutics" in the poster session. "By enabling researchers to overcome the bottleneck created by long lead times to build or buy their DNA or mRNA, they can more efficiently integrate their design-build-test cycles and quickly advance their discovery workflows. We believe our BioXp system can empower researchers to accelerate drug discovery, particularly in the areas of mRNA therapeutics and vaccines, Antibody discovery and engineering and Cell-Based immunotherapies," said Daniel Gibson, Ph.D., CTO and Co-founder of Telesis Bio.
|
GWGH | Hot Stocks09:09 EDT GWG Holdings solicits votes for Chapter 11 plan - On May 15, 2023, GWG Holdings announced that it and its fellow debtors-in-possession in the Chapter 11 cases pending at 22-90032 in the United States Bankruptcy Court for the Southern District of Texas Houston Division are soliciting votes for the Debtors' Further Modified Second Amended Joint Chapter 11 Plan, Submitted by the Debtors, the Bondholder Committee, and L Bond Management, LLC as Co-Proponents following the Court's approval of the Disclosure Statement for the Debtors' Second Amended Joint Chapter 11 Plan. The Plan is supported by the Official Committee of Bondholders, the fiduciary appointed in the Chapter 11 cases to represent the interests of all Bondholders . The Plan provides for the creation of two separate trusts-the Wind Down Trust and the Litigation Trust-each of which will monetize their respective assets with the goal of maximizing the value of those assets for the benefit of Bondholders and other creditors and equityholders. The Wind Down Trust will hold the beneficial interest in the Litigation Trust and will hold all of GWG's current assets. The assets to be held by the Wind Down Trust include all of GWG's interests in Beneficient, FOXO, and the Policy Portfolio. The Wind Down Trust will monetize its assets and distribute the net proceeds to Bondholders until they are paid in full, then, if any value remains, to other stakeholders. The Litigation Trust will receive all of GWG's litigation claims and all of GWG's interests in the D&O Liability Insurance Policies. The net amount recovered from the pursuit or settlement of these litigation claims will be distributed to the Wind Down Trust for further distribution as provided in the Plan. The Debtors and the Bondholder Committee believe that the Plan will result in greater recovery to Bondholders than would a liquidation under chapter 7 of the Bankruptcy Code.
|
ORMP | Hot Stocks09:08 EDT Oramed partner HTIT completes Phase 3 oral insulin clinical trial - Oramed Pharmaceuticals announced that Hefei Tianhui Biotechnology Co. Ltd., a strategic partner of Oramed, has successfully completed its Phase 3 trials of oral insulin in type 2 diabetes in China under a differentiated study protocol. HTIT is now moving toward regulatory approval and has submitted the data to the National Medical Products Administration. Oramed has recently completed an analysis of the data from its U.S.-based, Phase 3 trial, ORA-D-013-1, for the treatment of type 2 diabetes. This analysis found that subpopulations of patients with pooled specific parameters, such as body mass index, baseline HbA1c, age, gender and body weight, responded well to oral insulin. These subsets exhibited an over 1% placebo adjusted, statistically significant, reduction in HbA1c. The significant impact of baseline BMI on the responder group within the U.S. Phase 3 trial aligns with the positive data from the HTIT trial in China. The U.S. subpopulation and the Chinese general trial population shared a very similar baseline BMI.
|
HYMC... | Hot Stocks09:08 EDT Hycroft Mining Newmont acquires claims near Rosebud gold and silver mine - Hycroft Mining (HYMC) acquired claims near the historic past-producing high-grade gold and silver mine, Rosebud. The patented mining claims known as Lucky Boy 1, Lucky Boy 2, and White Alps were acquired by the company from Newmont (NEM) USA and are part of a 50% undivided interest with Hecla Mining (HL). In addition to the claims, the company also received a significant amount of data covering over 10,000 acres of land currently owned by Hycroft and adjacent to the known resource area. The Rosebud Mine, which operated during 1997 - 2000 through a joint venture between Newmont and Hecla, produced approximately 400,000 ounces of gold and over 2 million ounces of silver at an average grade of over 14 grams and 83 grams per ton, respectively. The proximity of this high-grade mine to the mineralized system at the Hycroft Mine gives Hycroft confidence in finding higher-grade ore and potential feeder systems.
|
LPLA | Hot Stocks09:07 EDT LPL Financial: Advisor team joins Institution Services platform - LPL Financial LLC announced today that financial advisors Indya Kellman, Tim Mol, CFP, and Pier Mutovic have joined LPL's Institution Services platform, aligning with Affinity Federal Credit Union's wealth management program. The advisors reported having served approximately $365 million in brokerage, advisory and retirement plan assets, They join from Raymond James. The three principal advisors are joined by financial advisors Kim Trimmer and Mike Tormey, CFP. With headquarters in New Jersey, New York and Connecticut, Affinity Federal Credit Union was founded in 1935 and has since expanded to 17 locations serving more than 200,000 members. Affinity Investment Services joined LPL's Institution Services platform in 2018 to help streamline operations, increase productivity and grow its investment services program.
|
BLNK | Hot Stocks09:06 EDT Blink Charging names Ritsaart van Montfrans as Chairman of the Board - Blink Charging announced that its Board of Directors elected Ritsaart van Montfrans as Chairman of the Board, at its May 10, 2023 Board meeting. van Montfrans has served on the Blink Board since December 2019.
|
NRSN | Hot Stocks09:06 EDT NeuroSense completes enrollment in Phase 2b ALS clinical trial - NeuroSense Therapeutics announced the completion of enrollment in PARADIGM, a multinational, randomized, double-blind, placebo-controlled Phase 2b clinical trial of PrimeC in people living with amyotrophic lateral sclerosis. Study participants are dosed for 6 months after being randomized 2:1 to receive PrimeC or placebo, respectively, followed by a 12-month open label extension phase, during which they receive PrimeC. NeuroSense anticipates topline results in Q4 2023. The study enrolled 69 participants living with ALS in Israel, Italy, and Canada. PrimeC has Orphan Drug Designation with the U.S. FDA and the European Medicines Agency. Topline results expected Q4 2023.
|
BALY | Hot Stocks09:05 EDT Bally's, GLPI, Oakland A's sign agreement for ballpark in Las Vegas - Bally's, in conjunction with Gaming & Leisure Properties, or GLPI, have reached a binding agreement with the Oakland Athletics of Major League Baseball to site their new ballpark on a portion of the current Tropicana Las Vegas property. The ballpark is expected to welcome more than 2.5 million fans and visitors annually. GLPI has agreed to fund up to $175M towards certain shared improvements within the future development in exchange for a commensurate rent increase. Bally's and GLPI will assign approximately nine acres of the 35-acre site located on Las Vegas Boulevard and Tropicana Avenue to the Oakland Athletics or a related stadium authority. The new ballpark will accommodate approximately 30,000 fans. This agreement is subject to the passing of legislation for public financing and related agreements, and approval of relocation by Major League Baseball. As part of the agreement, Bally's retains the ability to assign the rights to all aspects of this development and has received material interest from development partners. Bally's acquired the building and operations of the Tropicana Las Vegas from GLPI in September 2022 as part of a $148M transaction. Bally's entered into a 50-year ground lease with GLPI, with the ability to extend to 99-years upon achieving key investment milestones.
|
RCUS GILD | Hot Stocks09:03 EDT Arcus Biosciences jumps 2% amid expanded inflammation pact with Gilead - Shares of Arcus Biosciences (RCUS) are up 2% in pre-market trading to $18.85 per share after expanded inflammation pact with Gilead (GILD). Shares of Gilead are up fractionally to $78.44.
|
CPIX | Hot Stocks09:03 EDT Cumberland: FDA approves expanded labeling for Caldolor - Cumberland Pharmaceuticals announced that the U.S. FDA has approved expanded labeling for Caldolor, an intravenously delivered formulation of ibuprofen, to now include use in infants. The non-narcotic agent may now be administered for the treatment of pain and fever in patients three months to six months of age. The newly FDA-approved label includes information regarding the product's indications and usage, appropriate patient populations, clinical study results, potential side effects, patient safety details, and instructions for use in these young children.
|
AJG | Hot Stocks09:01 EDT Arthur J. Gallagher acquires RHP General Agency - Arthur J. Gallagher's subsidiary, Risk Placement Services, has acquired Houston, Texas-based RHP General Agency. Terms of the transaction were not disclosed. RHP is a managing general agency specializing in residential property insurance for clients throughout Texas. Greg Vanek and his team will remain in their current location under the direction of Russell Duffey, head of RPS' program administration division.
|
GDYN | Hot Stocks08:59 EDT Grid Dynamics releases Generative AI Product Design Starter Kit - Grid Dynamics Holdings announced the release of its Generative AI Product Design Starter Kit to complement other Gen AI offerings. Leveraging this starter kit, retailers, brands, and manufacturers can rapidly build unique digital services for their customers and improve the productivity of content creation teams using state-of-the-art generative AI technologies. Brands and manufacturers can leverage the Generative AI Product Design Starter Kit to enhance their design ideation processes, speed up prototyping, and provide customers with unique product personalization capabilities.
|
MACE | Hot Stocks08:59 EDT Mace Security announces notification of late filing - Mace Security International announced that its March 31, 2023 Unaudited Financial Statements and Notes and 2023 Q1 OTCQX Quarterly Report cannot be filed within the prescribed date because the Company requires additional time to prepare its financial statements and quarterly reports. The Company anticipates filing these two reports by May 20 - June 2, 2023.
|
YECO | Hot Stocks08:55 EDT EV Biologics signs distribution agreement with INNOVARE for South America - EV Biologics signed an exclusive multi-year agreement with INNOVARE for distribution in South America. This agreement will facilitate the launch, in South America and the Caribbean, of EV Biologics regenerative health products, which are currently in production by its wholly owned subsidiary, EXCYTE. INNOVARE has long standing relationships and agreements in place with established medical product companies, which have direct distribution channels throughout South America and the Caribbean. With Joint Ventures already in place, this agreement will provide direct contact with over 11,000 top private-practice physicians and surgeons representing all the medical specialties. INNOVARE will also conduct extensive training modules on these regenerative health products and how they may address patients' multifaceted and multifactorial health issues and support cardiovascular, dermatologic, neurologic, and musculoskeletal health and longevity. The Company will be seeking agents and sole agents in Asian countries for distribution as well.
|
BLBD | Hot Stocks08:54 EDT Blue Bird CEO Matthew Stevenson to depart, Phil Horlock to succeed - Blue Bird announced that Phil Horlock will again lead the company as CEO. Blue Bird's board of directors has appointed Phil Horlock to assume the position of president and CEO, effective immediately. Horlock held this position for nearly 11 years between 2011 and 2021 and presently serves on the board of directors. Matthew Stevenson, president and CEO of Blue Bird, is leaving the company for personal reasons. Stevenson has also exited his position on the board of directors.
|
TBMC | Hot Stocks08:53 EDT Trailblazer Merger I announces separate trading of common stock, rights - Trailblazer Merger Corporation I announced that, commencing May 15, 2023, shares of the Company's Class A common stock and rights, which together comprise the units sold in the Company's initial public offering, will begin separate trading. At such time, holders will hold the separate securities and no longer hold units, and the units will no longer trade. The separated Class A common stock and rights are expected to trade on the Nasdaq Global Market under the symbols "TBMC" and "TBMCR," respectively. No fractional rights will be issued upon separation of the units and only whole rights will trade. The units were initially offered by the Company in an underwritten offering. LifeSci Capital LLC and Ladenburg Thalmann & Co. Inc. acted as joint book-running managers of the offering. A registration statement relating to the units and the underlying securities was declared effective by the Securities and Exchange Commission on March 28, 2023.
|
GILD RCUS | Hot Stocks08:52 EDT Expanded Gilead- Arcus pact may result in up to $1B in payments to Arcus - Expanded research collaboration may result in up to $1B in option fees and milestone payments by Gilead (GILD) to Arcus (RCUS)
|
DOX MSFT | Hot Stocks08:50 EDT Amdocs 5G Experience Lab collaborates with Microsoft - Amdocs (DOX) revealed new use cases developed with Microsoft (MSFT) in its Americas 5G Experience Lab in Dallas, Texas, offering a look at how private networks, edge computing solutions, Internet of Things and more can come together for a better digital society. Amdocs's solutions are built on Microsoft Azure private MEC and Azure Private 5G Core which are tailored to different enterprise needs, taking a purpose-fit approach to the network compared to a one-size-fits-all method. Among the use cases now availablein the Azure Marketplace are the following: An end-to-end offering to enable Smart Cities, bringing together the software, connectivity, and physical hardware required for a secure solution. Cities can add intelligent, efficient lighting services, public/private internet access capabilities and a series of city management capabilities by providing real-time environmental and movement data. A complete AR Maintenance and Training offering that makes teams more effective, enabling a remote-assist workflow by which field technicians can access centralized expertise to support the completion of their service or maintenance task. The remote expert can see what the technician in the field can see, providing support or education, and the job can be documented in real-time.
|
HILS | Hot Stocks08:48 EDT Hillstream BioPharma appoints Anderson to its board of directors - Hillstream BioPharma announced the appointment of Kelly Anderson to its Board of Directors and committees, effective as of May 9, 2023. Anderson brings over 25 years of experience in public company finance, accounting and corporate governance across a variety of industries. Kelly Anderson currently serves as Chief Executive Officer of CXO Executive Solutions, a specialized executive talent solutions company.
|
NRG | Hot Stocks08:48 EDT Elliott sends letter to NRG Energy presenting 'a clear path forward' - Elliott Investment Management L.P., which manages funds that have an investment of approximately $1B representing a more than 13% economic interest in NRG Energy, sent a letter to the Board of Directors of NRG. According to the letter, the purpose of the materials is to present a clear path forward for how best to remedy NRG's meaningful underperformance and create significant and sustainable value. Elliott believes that successful execution of this plan could create over $5B of shareholder value, driving the company's stock price to reach or exceed $55 per share, the letter said. Elliott looks forward to meeting with the Board in the near term to work constructively with the company toward the implementation of a new value creation plan. Reference Link
|
GILD RCUS | Hot Stocks08:48 EDT Arcus to receive upfront payment of $35M from Gilead in expanded research pact - Gilead Sciences (GILD) and Arcus Biosciences (RCUS) announced that the companies have expanded the previously announced research collaboration focused on oncology to include therapies for the treatment of inflammatory diseases. The expanded collaboration builds upon Gilead's growing presence in inflammatory disease and serves as a step towards broadening Arcus' capabilities and portfolio beyond oncology and into inflammation. "We are pleased to build upon Gilead's efforts in inflammation with the expansion of our strategic collaboration with Arcus," said Flavius Martin, M.D., Executive Vice President, Research, Gilead Sciences. "Gilead is committed to accessing innovative approaches to address the significant unmet medical needs across a range of inflammatory conditions, and this expanded collaboration with Arcus underscores that commitment. Arcus is an excellent partner with clear strengths in discovery and development, and we believe this partnership will significantly accelerate our progress in developing transformative new therapies for inflammatory diseases." Under the terms of the expanded collaboration, Arcus will receive an upfront payment of $35M and will initiate research programs against up to four targets jointly selected by the parties that are applicable to inflammatory diseases. Gilead may exercise an option to license each program at two separate, prespecified time points. If Gilead exercises its option at the earlier time point for the first two target programs, Arcus would be eligible to receive up to $420M in option and milestone payments and tiered royalties for each optioned program. For any other option exercise by Gilead for the four target programs, the parties would have rights to co-develop and share global development costs and to co-commercialize and share profits in the United States for optioned programs. Beginning in the first quarter of 2022, consistent with recent industry communications from the U.S. Securities and Exchange Commission, Gilead no longer excludes acquired IPR&D expenses from its non-GAAP financial measures. This transaction with Arcus is expected to reduce Gilead's GAAP and non-GAAP 2023 EPS by 2c.
|
PLNT | Hot Stocks08:45 EDT Planet Fitness announces start of its High School Summer Pass program - Planet Fitness officially kicks off its High School Summer Pass program , opening its doors to high schoolers ages 14 - 191 to work out for free this summer through August 31 at any of the more than 2,400 Planet Fitness locations throughout the United States and Canada. "We're excited to officially open our doors to high school students today and provide a safe and Judgement Free space for teens to focus on their mental and physical health this summer as part of our High School Summer Pass program," said Chris Rondeau, Chief Executive Officer at Planet Fitness. "At Planet Fitness, we're proud of our commitment to give teens free access during the summer so they can develop long-lasting, healthy habits and experience all the benefits of fitness."
|
IE | Hot Stocks08:45 EDT Ivanhoe Electric, Ma'aden sign definitive agreement for JV, investment - Ivanhoe Electric announced the signing of a Definitive Agreement with Saudi Arabian Mining Company Ma'aden, finalizing the terms of the transactions announced on January 11, 2023. At closing, Ma'aden and Ivanhoe Electric will form a 50/50 exploration joint venture in Saudi Arabia to explore for copper, nickel, gold, silver and other electric metals. Ivanhoe Electric is the operator of the Joint Venture during the exploration phase, and Ma'aden will become the operator for the development of any economically viable deposits found and specifically designated by the Joint Venture. The Joint Venture will deploy the Typhoon geophysical surveying system in the largest exploration program ever conducted using the technology. Typhoon is the brand name for Ivanhoe Electric's proprietary electrical geophysical surveying transmitter, which can detect the presence of sulfide minerals containing copper, nickel, gold and silver. At closing, Ivanhoe Electric expects to issue approximately 10.2 million common shares to Ma'aden, representing 9.9% of common shares outstanding, at a purchase price of $12.38 per share for gross proceeds of US$126.5 million. US$66 million of proceeds will go to the Joint Venture to fund exploration activities, including the purchase of three new-generation Typhoon machines to be used by the Joint Venture. The remaining US$60 million will be retained by Ivanhoe Electric to advance its portfolio of US mineral projects, and for working capital and general corporate purposes. As part of the equity private placement, Ivanhoe Electric will grant Ma'aden a top-up right allowing Ma'aden to maintain its 9.9% ownership, and Ma'aden will agree to a five-year standstill limiting its shareholding to a maximum of 19.9%, subject to certain exceptions. Ma'aden will have the right to appoint a nominee to the Ivanhoe Electric board of directors. The transactions are expected to close by the end of Q2 2023 subject to the approval of a supplemental listing application by the New York Stock Exchange and the corporate and regulatory formalities required in Saudi Arabia to incorporate the joint venture entity.
|
OMH | Hot Stocks08:45 EDT Ohmyhome signs MOU with Ohmyhome Property to expand into Philippines - Ohmyhome and Ohmyhome Property announces the signing of a Memorandum of Understanding, MOU, of a strategic investment by Ohmyhome into Ohmyhome Property Inc.'s Philippines operations, marking Ohmyhome's plan of expanding in the large and growing Philippines market. "Philippines has always been a great market for property transactions. The quality of developers and their projects have improved significantly over the decades, and the country's economy has seen a strong rebound from COVID with a flourishing digital economy," said Rhonda Wong, Chief Executive Officer "Many companies have set up their Business Process Outsourcing and technology teams here, creating job opportunities and income for families. The growing Overseas Filipino Workers have also been a strong pillar of growth of the real estate industry. We believe that there are ample opportunities for a data-driven technology platform like us to help homebuyers, home sellers, and developers transact their properties." added Wong.
|
TGAN | Hot Stocks08:43 EDT Transphorm appoints Dr. Primit Parikh as President and CEO - Transphorm announced that its Board of Directors has appointed Dr. Primit Parikh as President and Chief Executive Officer of the Company and as a member of the Board. The Board also appointed Dr. Umesh Mishra to serve as Chair of the Board. Both of these appointments are effective May 15. Dr. Parikh and Dr. Mishra, who co-founded the Company's main operating subsidiary Transphorm Technology, succeed Mario Rivas, who has served as the Company's Chief Executive Officer since February 2020 and Chair of the Board since May 2022 and, as Transphorm Technology's Chief Executive Officer since October 2015. Mr. Rivas's retirement is part of the Company's management succession planning. Mr. Rivas will enter into a consulting agreement to provide advisory services to the Company through May 15, 2024. "We are very pleased to have Primit and Umesh take over the leadership of Transphorm following my retirement," said Mario Rivas, Transphorm's former CEO and Chairman. "We are confident that with their leadership the Company will continue to be a leader in the growing GaN semiconductor space." "
|
WW | Hot Stocks08:42 EDT WW appoints Comonte to board of directors - WW International, known as WeightWatchers, announced that Tara Comonte, CEO of TMRW Life Sciences, TMRW, has been appointed to the WeightWatchers Board of Directors, effective as of June 1, 2023.
|
APLD | Hot Stocks08:41 EDT Applied Digital launches AI Cloud services - Applied Digital Corporation announced the launch of its Artificial Intelligence, AI, Cloud services that will provide high-performance computing power for AI applications, including large language model training, graphics rendering, and more. The AI Cloud services will be offered through Sai Computing, a wholly-owned subsidiary of Applied Digital, and will serve as the brand through which the services will be marketed. The service will initially be provided from the Company's new 9MW HPC Jamestown facility which currently hosts a cluster of Nvidia A100, A40, and A6000 GPUs. The Company has customer commitments to fully utilize the initial capacity that is expected to be online this week. "According to a recent industry report1, the global artificial intelligence market is expected to grow at a CAGR of about 23% in the forecast period of 2023-2028 to reach a value of about US $6 trillion by 2026," said Applied Digital CEO and Chairman, Wes Cummins. "Applied Digital's differentiated datacenter infrastructure uniquely positions us to meet the sophisticated and demanding workloads required for businesses to leverage AI and other HPC applications," Cummins added. "With the launch of our AI cloud service, we are able to expand our offerings and further capitalize on the unprecedented demand we are seeing from customers for our services. Applied Digital aims to be at the forefront of providing the next generation of needed services that enable and deliver on the untapped future of AI."
|
HTLZF | Hot Stocks08:41 EDT Hamilton Thorne expects some tailwinds in 2H23 - Mr. Wolf continued, "We continue to feel that our company is in a great position as demand for our products and services remains strong. We expect solid sales performance, based on the positive trends in our field and as demand and growth in local currencies have returned to pre-pandemic levels in nearly every market that we serve. Also, while we faced 4-5% currency headwinds in Q1 if the current trends continue, we should see some tailwinds in the second half of the year." Commenting on the Company's M&A activities, Mr. Wolf stated, "We have an extensive pipeline and are actively working on multiple acquisition opportunities. With significant cash on hand, our unused line of credit, and further debt capacity, we are well positioned to continue to execute on our acquisition program.
|
MNMD | Hot Stocks08:39 EDT FCM NN says MindMed CEO's claim Phase IIb is required by FDA is incorrect - FCM MM, which together with its affiliates beneficially owns 1,368,538 common shares of Mind Medicine, representing approximately 3.5% of the outstanding common shares of the Company, today announced that it has analyzed each of the 63 Central Nervous System drugs approved by the U.S. Food and Drug Administration in the last decadei and concluded that MindMed Chief Executive Officer Robert Barrow's claim that a Phase IIb of MM-120 is required by the FDA is categorically incorrect. In its analysis, FCM determined that 66% of the CNS drugs did not perform a Phase IIbii and 22% skipped Phase IIiii altogether. FCM's comprehensive study demonstrates that the industry gold standard for CNS drugs is to perform dose finding in Phase III, a strategy FCM has been advocating that MindMed pursue for MM-120 for close to a year. "The stark disparity between MindMed's approach on MM-120 and every other approved CNS drug in the past decade is perplexing," said Dr. Scott Freeman, co-founder and formerly MindMed's Chief Medical Officer. "MM-120 is well characterized. This is a perfect example of a situation where bypassing a Phase IIb study and performing a Phase III dose finding study to save time and money is possible, since the only question is whether 50 undefined or 100 undefined of MM-120 is the lowest effective dose. In our view, Mr. Barrow's contention that the FDA requires a Phase IIb study demonstrates a complete lack of understanding of the drug development process. Our approach would be to follow the industry gold standard, which is to pursue a Phase III dose finding study, a strategy that companies like AbbVie, Pfizer, and Amgeniv have successfully used to get CNS drugs FDA approved," added Dr. Freeman.
|
SILC | Hot Stocks08:39 EDT Silicom selected by U.S. telecommunications services provider - Silicom has been selected to develop an Edge Networking product by an U.S.-based provider of enterprise telecommunications services. The customer has already placed initial orders totaling approximately $5M. Delivery of products will commence following successful completion of the development and testing processes, which are expected to be carried out by the end of 2023. The customer has indicated that orders will scale up over the next several years as the product enters mass deployment.
|
AROW | Hot Stocks08:36 EDT Arrow Financial receives Nasdaq notice of non-compliance - Arrow Financial announced that the company is noncompliant with the periodic filing requirements for continued listing set forth in Nasdaq Listing Rule 5250(c)(1) as a result of its failure to file its Annual Report on Form 10-K for the year ended December 31, 2022 with the Securities and SEC by the required due date.
|
STRR SVVC | Hot Stocks08:36 EDT Star Equity launches proxy solicitation for Firsthand Technology Value Fund - Star Equity Fund (STRR) owns 6.2% of the common stock of Firsthand Technology Value Fund (SVVC) and, for the benefit of all SVVC shareholders, announced that it has filed its definitive proxy statement with the Securities and Exchange Commission and commenced soliciting proxies urging all shareholders to vote the WHITE proxy card to elect its director nominees Robert G. Pearse and Hannah M. Bible to the Company's board of directors at the Company's 2023 annual meeting of shareholders. SVVC's Annual Meeting will be held in a virtual format on May 26, 2023, at 5:00 p.m. ET / 2:00 p.m. PT. The company said, "Our two nominees, Robert G. Pearse and Hannah M. Bible, are qualified, fully committed, and ready to maximize shareholder value for all shareholders at SVVC. Mr. Pearse has extensive experience as both a venture capitalist and corporate executive and engineer for technology companies in Silicon Valley such as the Hewlett-Packard Company (n/k/a HP Inc.) and NetApp, Inc. We believe Mr. Pearse's business development experience as well as his technical and financial acumen will make him a valuable addition to the Board. Ms. Bible has over 20 years of legal experience and has served as director and chair on the boards of several public companies. We believe that Ms. Bible's significant legal experience across a variety of industries, corporate governance expertise, and her prior public company board experience makes her well qualified to join the Board. If elected to the Board, our nominees would push for: Immediate termination of the investment management agreement with FCM. Changing the anti-shareholder bylaws including the voting requirements on director nominees. Better facilitation of shareholder input and participation at the Company. Changing the overall strategy of SVVC to a traditional BDC; Cease making venture capital investments. Instead, issue interest-bearing loans to less speculative portfolio companies. Reinstate a regular dividend in order to help the stock price converge with NAV per share over time. Star Equity Fund remains resolute in its opinion that a change in Board composition is vital to altering corporate governance practices, improving financial results, and ultimately unlocking shareholder value at SVVC. We believe long-suffering SVVC shareholders deserve better, and we aim to give them an opportunity for much-needed change on the Board at the 2023 Annual Meeting."
|
NBIX | Hot Stocks08:36 EDT Neurocrine presents results of Ingrezza capsules in dyskinesia and schizophrenia - Neurocrine announced findings from a post hoc analysis of two long-term studies of Ingrezza - valbenazine - capsules evaluating global tardive dyskinesia - TD - improvement and stability of psychiatric symptoms in adults with TD and schizophrenia or schizoaffective disorder. The post hoc analysis found that patients with TD and schizophrenia or schizoaffective disorder who received long-term treatment with once-daily Ingrezza while receiving concomitant, stable-dose medications for maintenance of their psychiatric condition experienced long-term global improvements in TD, with more than 90% of patients having a rating of "minimally improved" or better, and more than 75% of patients having a rating of "much improved" or better. Patients maintained psychiatric stability throughout treatment with Ingrezza. Tardive dyskinesia is a movement disorder that is characterized by uncontrollable, abnormal, and repetitive movements of the face, torso and/or other body parts, which may be disruptive and negatively impact patients. More than 75 percent of Ingrezza-treated patients had robust global improvements, as indicated by CGI-TD or PGIC ratings of "much improved" or better. The study met its primary endpoint of change-from-baseline in AIMS at week six in the 80 mg once-daily dosing group compared to placebo as assessed by expert central blinded video raters. Ingrezza was generally well tolerated throughout 48 weeks of treatment.
|
SGRP | Hot Stocks08:35 EDT Spar Group postpones Q1 earnings report - Spar Group announced that it is postponing its earnings report and conference call to allow for additional time for the company and the company's external auditors to complete their work on first quarter's results. Although the company's external auditors are finalizing their work, the company currently anticipates revenue for the three months ended March 31, 2023 to be $64M, up 9.1%, with gross margin expansion for the quarter compared to the prior year quarter, as well as operating income up over 50% compared to the prior year quarter. The company will issue the earnings report upon the completion of the external auditor's quarterly review.
|
AROW | Hot Stocks08:33 EDT Arrow Financial: David DeMarco to succeed Thomas Murphy as CEO - Arrow Financial announced that Thomas Murphy terminated his employment as President and CEO of the company and its lead subsidiary, Glens Falls National Bank and Trust Company and as a director of the company and from all other positions he holds with the company and its affiliates, effective May 12. The company also announced that the Board of Directors has appointed Chief Banking Officer and Senior Executive Vice President David DeMarco as President and CEO of Arrow and its lead subsidiary, Glens Falls National Bank and Trust Company. DeMarco, who has been with the company for 35 years, will continue to serve as President and CEO of Arrow subsidiary Saratoga National Bank and Trust Company.
|
MULN | Hot Stocks08:32 EDT Mullen Automotive issues update on pilot program contract - Mullen Automotive issues an update on the pilot program contract for installation of Energy Management Modules on Washington, D.C., city government's fleet of vehicles. The $680,000 contract was previously awarded by the District of Columbia, Washington, D.C., to EV Technologies, LLC. for the purchase and installation of EMM units on Chevrolet Bolts within the D.C. city government's vehicle fleet. Mullen Advanced Energy Operations is supporting EV Technologies for the execution of the contract, which started April 24, 2023. MAEO, which is a 51%-owned subsidiary of Mullen Automotive, is a collaboration with Global EV Technology. MAEO has named Lawrence Hardge to the position of senior vice president of technology. Lawrence will be overseeing all technological aspects of the Energy Management Module applications.
|
CLDX | Hot Stocks08:29 EDT Celldex presents data from CDX-622 at IMMUNOLOGY2023 - Celldex Therapeutics announced preclinical data from CDX-622, the Company's bispecific antibody with dual targeting of the alarmin TSLP and stem cell factor, also known as KIT receptor ligand, developed from its bispecific antibody platform. TSLP and SCF have been shown to contribute to the pathophysiology of various inflammatory, fibrotic and allergic disorders. These data were presented in a poster session as part of IMMUNOLOGY2023, the annual meeting of the American Association of Immunologists. The preclinical data show CDX-622 potently neutralizes the alarmin TSLP, a potent mediator of inflammation, and blocks SCF/KIT interaction required for mast cell function and survival. CDX-622 was well tolerated and demonstrated a favorable pharmacokinetic profile as well as robust evidence of skin mast cell depletion in preclinical models. "Clinical studies with our KIT antibody, barzolvolimab, have demonstrated the significant potential of mast cell depletion through the inhibition of KIT. CDX-622 builds on this understanding and adds a second critical inflammatory pathway-TLSP mediated inflammation," said Tibor Keler, Ph.D., Executive Vice President and Chief Scientific Officer of Celldex Therapeutics. "The data presented at AAI demonstrate that we have successfully combined blockade of these two complementary inflammatory pathways into one molecule and support the further advancement of CDX-622, which we believe provides a unique opportunity to target multiple pathways in disease settings where using combination therapies is challenging."
|
BCTX | Hot Stocks08:28 EDT BriaCell announces $4M investment, MSTA with Prevail InfoWorks - BriaCell Therapeutics has signed a Master Service and Technology Agreement agreement with Prevail InfoWorks to provide clinical services and technologies for BriaCell's upcoming pivotal study in advanced metastatic breast cancer. Services include clinical site coordination, project management, clinical monitoring and pharmacovigilance services, and the use of InfoWork's integrated real-time data analytics platform, The Single Interface, for clinical support and real-time data analysis. Prevail Partners, an investment fund and affiliate of InfoWorks, has agreed to purchase 463,408 BriaCell common shares at a price of $8.63 for gross proceeds of $4 million, representing a 20% premium to the trailing thirty trading day volume-weighted average price of the common shares of the Company on the Nasdaq Stock Exchange. Subject to exchange approvals and other customary closing conditions, the subscription is expected to close on or about May 19, 2023.
|
WLDS QCOM | Hot Stocks08:27 EDT Wearable Devices appoints Kedia to advisory board as an Executive Advisor - Wearable Devices (WLDS) announced the appointment of Pankaj Kedia to its advisory board as an Executive Advisor. In this role, Kedia will help the company to accelerate the adoption of its technologies and grow its B2B and B2C product lines. Most recently, at Qualcomm (QCOM), Kedia founded the wearables business and established Snapdragon Wear as the pre-eminent leader in the wearables segment.
|
TU | Hot Stocks08:26 EDT Telus Health launches Total Metal Health across Canada - TELUS Health announced the launch of Total Mental Health - an innovative solution that provides employees with access to a team of care professionals who curate personal care journeys with unlimited mental health counselling, therapist-led iCBT programs, digital tools, assessments, and ongoing tracking and feedback. Accessible by employees through their company's health benefits, Total Mental Health leverages TELUS Health's world-leading technology to offer a one-stop app for mental health support through Canada's largest and most diverse network of counsellors.
|
SLGG | Hot Stocks08:25 EDT Super League Gaming consummates two private financings - Super League Gaming announces that it has consummated two private financings of convertible preferred stock, priced at the market under Nasdaq rules, with the final closing expected to occur later this week. The Company received aggregate gross proceeds of approximately $23.8 million in these financings from November 2022 through May 2023, before deducting placement agent fees and other offering expenses payable by the Company. The capital was raised from both existing and new investors and was used to extinguish the Company's debt and fund ongoing operations and growth initiatives. As a part of the private placement offering, the Company issued newly designated Convertible Preferred Stock. Each share of Preferred Stock was sold at $1,000 per share and is convertible into shares of common stock, subject to certain beneficial ownership limitations. Other material terms of the Preferred Stock financing, including the registration rights granted to investors, are described in the Company's Current Reports on Form 8-K filings made with the Securities and Exchange Commission to date and following the date above. SternAegis Ventures acted as the exclusive placement agent for this offering. Participants in the offering include existing investors, new investors, and affiliates of the placement agent.
|
SWAV | Hot Stocks08:24 EDT ShockWave announces full commercial availability of Shockwave C2+ Coronary IVL - Shockwave Medical announced the full commercial availability of the Shockwave C2+ Coronary Intravascular Lithotripsy, IVL, Catheter to treat severely calcified coronary artery disease in select international markets. Shockwave C2+ provides 50 percent more pulses per catheter than Shockwave C2 and is optimally designed to treat longer calcified lesions and more challenging eccentric and nodular calcium. "Shockwave C2+ maintains the intuitive catheter design and ease of use that are foundational to the success of Shockwave IVL and incorporates improvements that will enhance procedural efficiency and optimize the treatment of the most challenging morphologies," said Jonathan Hill, MD, Consultant Cardiologist at the Royal Brompton Hospital in London. "The extra pulses are most advantageous in areas with the highest burden of calcium, including nodular, eccentric, diffuse and multivessel calcium."
|
NAVI AXP | Hot Stocks08:23 EDT Navient names Yowan as President, CEO - Navient (NAVI) announced today that David Yowan, a member of the Navient board of directors and formerly corporate treasurer for American Express (AXP), has been appointed president and CEO of the company. He succeeds Jack Remondi in this role, effective May 15. Remondi, whose director term expires as of the 2023 Annual Meeting of Shareholders on May 25, will not be renominated to the board at the Annual Meeting. David Yowan has been a director of Navient since April 2017. He has chaired the Audit Committee and served on the Risk Committee.
|
SSKN | Hot Stocks08:21 EDT Strata Skin Sciences enters India market with agreement with Spectra Medical - STRATA Skin Sciences announced it has entered into an exclusive, three-year agreement with Spectra Medical India Pvt Ltd., a distribution company representing medical laser and aesthetic equipment manufacturers, for the distribution of TheraClearX, VTRAC, and XTRAC in India. "We are excited to expand into the acne, psoriasis, and vitiligo market in India with Spectra Medical," stated Bob Moccia, Chief Executive Officer of STRATA Skin Sciences. "Led by Ramamoorthy Sundaram, Spectra Medical has over 20 years of experience in the medical distribution industry, and is India's leading distributor of dermatology medical devices. India presents STRATA with a unique opportunity as there are no excimer laser solutions for phototherapy treatments currently available today. India has the highest prevalence of vitiligo in the world, and over 80% of young adults suffer from acne.2 We believe our products could potentially help to fill a gap in their market for effective, non-pharmaceutical treatment solutions."
|
VIR | Hot Stocks08:20 EDT Vir Biotechnology appoints Jeff Calcagno as EVP, CBO - Vir Biotechnology (VIR) announced the appointment of Jeff Calcagno, M.D., as Executive Vice President and Chief Business Officer. Dr. Calcagno will be responsible for leading the Company's business development efforts, optimizing existing alliances and establishing new strategic industry and public-private partnerships. He reports to Vir's Chief Executive Officer Marianne De Backer, M.Sc., Ph.D., MBA, and joins Vir's executive management team. Dr. Calcagno joins Vir from Johnson & Johnson (JNJ), where he spent more than 12 years holding leadership roles of increasing responsibility within all three divisions of J&J Innovation, including as Global Transactions Lead for Infectious Diseases & Vaccines and as Head of JLABS Bay Area.
|
DLHC | Hot Stocks08:20 EDT DLH Holdings awarded $18.6M contract to expand IT services for NIA - DLH Holdings announced that it has been awarded a contract to continue and significantly expand its IT services for the National Institute on Aging, NIA. The contract includes a base period of one year with four one-year options, with a total value of $18.6 million. Through this award, DLH will be responsible for driving key digital transformation goals for the NIA Intramural Research Program, such as DevSecOps and scientific poly-cloud enablement for high-performance computing and data science. The Company will provide a wide range of IT solutions in service of the customer's research-based mission, including integrating new and existing IT assets, applications, services, and systems; digital transformation; cloud enablement, cybersecurity ecosystem development, system architecture, systems administration, service desk and technician support, scientific programming, and more. "Through this award, DLH will leverage digital transformation and cybersecurity capabilities to advance our customer's vital health and scientific mission," added Zach Parker, DLH President and CEO. "This critical, complex work exemplifies the broad range of customer needs that DLH is now able to address and the types of valuable opportunities that are available to our company moving forward."
|
FMAO | Hot Stocks08:19 EDT F&M Bank unveils new branding including logo, shortened brand name - F&M Bank unveils a new, forward-looking logo. The new logo will be rolled out across the F&M market footprint throughout the summer. All branded materials will be changed effective immediately, while office signage will begin to change at all locations starting in June. The signage project is expected to be completed by September 2023. The logo and shortened brand name from Farmers & Merchants State Bank to F&M Bank was the culmination of a multi-year brand exploration process. The new logo was inspired by F&M's desire to honor its legacy, while looking towards the future. The three blue lines can subtly seen as the letter F for Farmers and the three teal lines can be as the three lines in an M from the bottom coming together in harmony to create a forward upward angled motion toward future thinking and innovation.F&M Bank has announced several expansion efforts for 2023, including a new regional headquarters in downtown Fort Wayne, Indiana as well as a new office in downtown Toledo, Ohio. The Bank's rebranding commits to their pledge that as times change, F&M will change with them, by growing, adding new locations and bringing new innovations to the way people bank.
|
MULN | Hot Stocks08:18 EDT Mullen Automotive provides business update - Mullen Automotive announces a business update to its shareholders. Recent Company Updates: MGT Lease Company, a national fleet sales and leasing provider, previously took delivery of Mullen EV Cargo Vans on March 30, 2023. The Company subsequently signed a vehicle purchase agreement, as announced on May 11, 2023, for 250 all-electric commercial Class 3 Cab Chassis EV Trucks. The contract is valued at $15.8 million and MGT expects to take possession of the vehicles between August and December of this year. All vehicle orders will be fulfilled through Randy Marion Automotive Group, a distributor of Mullen's commercial EVs. On April 18, 2023, the Company announced formation of Mullen Advanced Energy Operations, a collaboration with Global EV Technology, with initial development focused on improving energy management technology in electric vehicles for greater range and vehicle performance. Among the major milestones achieved by the Company to date has been the successful execution of Mullen's plan to deliver EV Cargo Vans to commercial customers before the end of March 2023. The first batch of EV Cargo Vans was fulfilled by Randy Marion Group to The University of North Carolina at Charlotte and MGT Lease Company in North Carolina, marking a significant step towards Mullen's goal of providing sustainable transportation solutions to businesses. In April, the Company successfully completed a 60-day pilot program in collaboration with Loop Global and Menzies Aviation for deployment of electric vehicles and charging infrastructure at Los Angeles International Airport.
|
PLAY | Hot Stocks08:18 EDT Dave & Buster's reschedules virtual Investor Day - Dave & Buster's Entertainment announced that it will report financial results for its first quarter ended April 30, 2023 after the market closes on Tuesday, June 6, 2023 and that the Company is rescheduling its virtual Investor Day to Tuesday, June 13, 2023.
|
BWAY | Hot Stocks08:16 EDT Brainsway launches Investigator Initiated Study program - BrainsWay announced the launch of its Investigator Initiated Study, IIS, Program. The program is designed to support further research on Deep Transcranial Magnetic Stimulation by the clinical research community through data collaboration and equipment loan initiatives. Applications will be accepted through July 3, 2023. "With superior science and superior evidence, BrainsWay continues to lead the TMS field with its IIS Program. Our goal is to support researchers in their efforts to advance neuroscience research by facilitating Deep TMS data development and furthering access to our novel equipment. The partnerships with academia that will be achieved through this program are a further testament to our longstanding commitment to moving the field forward by improving health and transforming even more patients' lives," said Colleen Hanlon, Ph.D., Vice President of Medical Affairs. The program will aid investigators interested in advancing current knowledge about Deep TMS. Applications will be granted based on criteria of clinical and scientific significance, scope, innovation, and applicability. Applications by early-career investigators and those which utilize BrainsWay's patented Deep TMS H4 Coil are strongly encouraged.
|
HBI | Hot Stocks08:16 EDT Hanesbrands and Penn State announce multi-year apparel partnership extension - HanesBrands and Penn State announced a multi-year extension of their current apparel partnership that gives HBI exclusive rights in the mass retail channel. The global apparel company, which owns the iconic Champion and Hanes brands, has a decades-long partnership with Penn State...In addition to the mass retail channel, the partnership includes collaborative retail activations marking key rivalries and events. The partnership extension with HanesBrands, which includes apparel like tees, sweats and jackets was completed in conjunction with the university's exclusive licensing agent, CLC.
|
TARA | Hot Stocks08:15 EDT Protara announces dosing of first patients in Phase 1b ADVANCED-1EXP trial - Protara Therapeutics announced that patient dosing is now underway in its Phase 1b ADVANCED-1EXP expansion trial evaluating TARA-002, the Company's investigational cell-based therapy, for the treatment of patients with high-grade non-muscle invasive bladder cancer who have carcinoma in situ. "Following positive preliminary results from the ADVANCED-1 trial, we are pleased to have dosed the first patients in our ADVANCED-1EXP trial," said Jathin Bandari, M.D., Chief Medical Officer of Protara Therapeutics. "We believe TARA-002 has the potential to play a meaningful role in the NMIBC treatment landscape, as there continues to be limited treatment options for this highly recurrent disease. We look forward to gaining additional clinical experience with TARA-002 in NMIBC patients with CIS."
|
TGL | Hot Stocks08:15 EDT Treasure Global announces brand partnership for Zstore Affiliate Program - Treasure Global announced an exclusive partnership with enogy, a health and wellness brand, to expand the range of products available on its e-commerce marketplace, Zstore, targeting the large and growing health and wellness industry. As part of the partnership, enogy products will be exclusively available in the Zstore marketplace within the ZCITY app, a digital entrepreneurship platform. In addition, Treasure Global will promote enogy products to its expanding database of Zmembers, leveraging a combination of conventional and cutting-edge digital marketing strategies to quickly target ZCITY users.
|
NVCT | Hot Stocks08:13 EDT Nuvectis Pharma announces FDA clearance of NXP900 IND - Nuvectis Pharma announced that the U.S. Food and Drug Administration cleared the Company's Investigational New Drug Application for NXP900, which includes the Phase 1 clinical trial protocol.
|
MNDY | Hot Stocks08:07 EDT Monday.com jumps 17% to $153 per share after Q1 results, FY23 guidance raise
|
MMM | Hot Stocks08:07 EDT 3M announces departure of Chief Business and Country Officer Michael Vale - 3M announced that Michael Vale has been terminated for cause from the company, effective May 12. His dismissal is due to inappropriate personal conduct and violation of company policy, unrelated to the company's operations and financial performance. When 3M learned of and verified the violation, it took immediate action. The company has initiated a search for Vale's successor. Effective immediately, the leaders of 3M's Safety and Industrial Business, Consumer Business, and Transportation and Electronics Business report to 3M chairman and CEO Mike Roman.
|
BWMN | Hot Stocks08:06 EDT Bowman Consulting acquires Fisher Engineering, sees immediate accretion - Bowman Consulting Group announced the purchase of Fisher Engineering , a professional services firm specializing in customized fire protection and life safety engineering for public and private customers. "We've been pursuing the acquisition of Fisher for quite some time," said Gary Bowman, CEO of Bowman. "Fisher has built a great platform from which we can expand a national and international fire protection and life safety practice. Doug and the Fisher team possess a depth of expertise that complements the services we offer and aligns perfectly with our extensive customer base. Fisher's experience as a prime contractor to the United States federal government will provide us a pathway to expand our reach to the single largest infrastructure consumer in our market. We're all looking forward to realizing the inherent revenue synergies that will come from this acquisition." The Company expects the Fisher acquisition to contribute approximately $5M of annualized net service billing before revenue synergies and be immediately accretive. Financed with a combination of cash, seller notes, and equity, the acquisition falls within previously discussed target multiple and operating metric ranges. More detailed information on M&A activities, pipeline, and guidance updates will be provided in connection with scheduled quarterly and annual communications.
|
SVM | Hot Stocks08:05 EDT Silvercorp Metals signs term sheet for acquisition of Celsius Resources - Silvercorp Metals has signed a non-binding term sheet with Celsius Resources regarding a proposed transaction pursuant to which Silvercorp will acquire all of the issued and outstanding shares of Celsius. The addition of Celsius' advanced-stage Maalinao-Caigutan-Biyog copper-gold project in the Philippines to Silvercorp's underground silver mining operations will move Silvercorp into being a diversified precious-base metals producer. Silvercorp has offered to acquire all of the outstanding shares of Celsius from the shareholders of Celsius, at a fixed price of AUD$0.030 per share, in exchange for consideration comprising 90% Silvercorp shares + 10% in cash. The consideration of AUD$0.030 per share represents a 76% premium to the 20-day volume weighted average price of Celsius as of the close of trading on the ASX on May 11. The total consideration is approximately AUD$56M. The proposed transaction will result in Silvercorp issuing approximately 9.7 million shares and paying AUD$5.6M to the shareholders of Celsius. Celsius and Silvercorp have also executed a private placement subscription agreement at AUD$0.015 per Celsius share for a total of AUD$5M. This will provide interim funding for further development of Celsius' MCB Project. On closing of the private placement, Silvercorp will own approximately 15% of the outstanding shares of Celsius. In addition to the consideration, Celsius shareholders will receive shares in a new exploration company - Spinco - which will hold all of Celsius' rights and interests with respect to the Sagay and Opuwo projects. The Spinco shares will be distributed on a 10 Celsius shares for 1 Spinco share basis. Spinco will seek a listing on the ASX or London Stock Exchange Alternative Investment Market via a demerger and concurrent initial public offering. Silvercorp has agreed to invest AUD$4M in Spinco, valued at a post-financed market capitalization of AUD$30M.
|
SAP MSFT | Hot Stocks08:05 EDT SAP, Microsoft collaborate on joint generative AI offerings - SAP (SAP) announced the next step in its long-standing partnership with Microsoft (MSFT), using the latest in enterprise-ready generative AI innovation to help solve customers' most fundamental business challenges. The companies will collaborate on integrating SAP SuccessFactors solutions with Microsoft 365 Copilot and Copilot in Viva Learning, as well as Microsoft's Azure OpenAI Service to access powerful language models that analyze and generate natural language. The integrations will enable new experiences designed to improve how organizations attract, retain and skill their people.
|
COLB | Hot Stocks08:04 EDT Columbia Banking raises quarterly dividend 20% to 36c per share - The dividend is payable June 15 to shareholders of record as of May 31.
|
OCUP | Hot Stocks08:03 EDT Ocuphire Pharma expects cash to fund operations into 2025 - As of March 31, 2023, Ocuphire had cash and cash equivalents of approximately $39.0 million. The Company has no debt. Based on current projections, management believes the present cash on hand will be sufficient to fund operations into 2025.
|
EBS BVNRY | Hot Stocks07:59 EDT Emergent BioSolutions sells travel health business to Bavarian Nordic - Emergent BioSolutions (EBS) announced it has completed the sale of its travel health business to Bavarian Nordic (BVNRY). At closing Emergent received $270 million, subject to customary closing adjustments, and may receive up to an additional $110 million in potential future milestone payments. With the transaction closed, Bavarian Nordic has acquired the rights to Vivotif, the licensed typhoid vaccine, and Vaxchora, the licensed cholera vaccine, as well as the development-stage chikungunya vaccine candidate CHIKV VLP. Bavarian Nordic also acquired manufacturing facilities in Bern, Switzerland, and development facilities in San Diego, California. The majority of Emergent employees supporting these products and facilities are joining Bavarian Nordic.
|
BFH | Hot Stocks07:56 EDT Bread Financial reports loans at April-end $18.04M vs. $17.22M last year - Reports net principal losses at April-end $114M vs. $73M last year. Reports April delinquency rate 5.5%.
|
ASGOF | Hot Stocks07:54 EDT Asante Gold reports higher mineral resources in amended Chirano mine report - Asante Gold announces the filing of an amended technical report entitled "Amended NI 43-101 Technical Report, Chirano Gold Mine, Ghana, West Africa" in accordance with National Instrument 43-101 - Standards of Disclosure for Mineral Projects in connection with the Company's Chirano Gold Project, located immediately south of the Company's Bibiani Gold Mine. The Amended Technical Report therefore results in an increase in total Measured and Indicated Mineral Resources from 1.13 Moz to 2.12 Moz broken down as follows: Underground Measured and Indicated Mineral Resources of 11.05Mt at 1.88 g/t Au exclusive of any Mineral Reserves; Open pit Measured and Indicated Mineral Resources of 17.05Mt at 0.85 g/t Au exclusive of any Mineral Reserves; Mine Mineral Reserves of 15.760 Mt at 1.95g/t Au
|
GOLD | Hot Stocks07:54 EDT Midland enters definitive agreement with Barrick on Patris property - Midland Exploration announces the signing of a definitive option agreement with a wholly-owned indirect subsidiary of Barrick Gold Corporation for its Patris gold property (the "Property"), currently wholly-owned by Midland and located about 35 kilometres northeast of the town of Rouyn-Noranda, Quebec. Pursuant to the Transaction, Barrick has the right to acquire up to a 75% interest in the Property in consideration for cash payments totaling C$1,017,500 and exploration work totaling C$16,575,000, over an eight-year period. Barrick will be the operator of the work carried out under the Transaction. Barrick may earn an initial 51% interest in the Property over a period of four years, by paying in cash C$392,500 to Midland and funding expenditures of at least C$4,000,000, including a guaranteed amount of C$3,000,000, at which point Barrick and Midland will form a joint venture. In the following two years, Barrick may earn an additional 9% in the JV, for a 60% interest in consideration for cash payments totalling C$265,000 and exploration work expenditures of at least C$2,000,000. Finally, in the subsequent two years, Barrick may earn an additional 15% in the JV, for a total 75% interest in consideration for cash payments totalling C$360,000 and exploration work expenditures of at least C$10,575,000. If Barrick does not exercise or complete the First JV Funding or the Second JV Funding Option, the JV interests will be subject to any subsequent adjustments in ownership made in accordance with the proportionate funding and dilution terms of the JV agreement. Dilution below a 10% JV interest results in conversion of the JV interest to a 2% NSR royalty with the right to repurchase 50% of the NSR royalty for a payment of C$1,500,000.
|
XPO | Hot Stocks07:51 EDT XPO Logistics announces proposed term loan refinancing transaction - XPO intends to refinance a portion of its existing senior secured term loan facility due February 2025 with approximately $700 million of new senior secured term loans maturing in 2028. In connection with the Term Loan Refinancing, XPO anticipates refinancing additional amounts outstanding under its existing senior secured term loan facility and paying related fees, expenses and accrued interest with the proceeds of approximately $830 million of additional senior secured debt and approximately $450 million of additional senior unsecured debt, subject to market and other conditions. The remaining portion of XPO's existing term loans are expected to be repaid with cash on hand in the second quarter of 2023.
|
DBTX | Hot Stocks07:51 EDT Decibel Therapeutics expects cash to fund operations into first half of 2024 - Based on its current operating and development plans, Decibel believes that its existing cash, cash equivalents and available-for-sale securities will fund its planned operating expenses into the first half of 2024.
|
SAWLF | Hot Stocks07:50 EDT Shawcor announces voting results from annual meeting - Shawcor announced, in accordance with Toronto Stock Exchange requirements, the voting results from its Annual Meeting held May 12, 2023 in Toronto, Ontario. A total of 45,841,374 common shares were voted at the meeting representing 65.67% of the votes attached to all outstanding shares. Shareholders voted in favour of all items of business before the meeting, including the election of all director nominees. A special resolution to change the name of the organization to Mattr Corp. or another name approved by the Board of Directors was brought forward at the Annual Meeting.
|
DIIBF | Hot Stocks07:48 EDT Dorel Industries reaffirms outlook provided in March - "The outlook we provided in March when we released our year-end results remains the same. The retail environment in the U.S. has not changed as of now and orders from our retail partners have not picked up. As expected, this is most pronounced at Dorel Home. Dorel Juvenile slightly underperformed, but our market share gains and recent new product announcements lead us to be optimistic about a quick turnaround at Juvenile", commented Dorel President & CEO, Martin Schwartz. "Early April Juvenile sales were dampened by the network outage, but May and June currently look strong. We expect this strength to continue for the balance of the year based on our latest product portfolio and a stable cost environment, translating into profits beginning in May. At Dorel Home, we are encouraged by the latest order levels and our inventory average cost was lower as we started the quarter. Unfortunately, we do not see a return to operating profit until at least the third quarter for this segment. Both our segments did a good job bringing down inventory levels in the first quarter, generating over US$50.0 million in cash. This had the double benefit of moving out higher cost inventory and strengthening our balance sheet. Going forward, we have newer, lower cost inventory and our gross margins are expected to improve. The positive currency and cost environment that we have seen in the first quarter is expected to remain unchanged and will also contribute to better earnings. I want to thank our entire organization for their genuine efforts on turning around our business and look forward to better results ahead," concluded Mr. Schwartz.
|
LAB BSX | Hot Stocks07:47 EDT Standard BioTools appoints Jeffrey Black as Chief Financial Officer - Standard BioTools (LAB) announced the appointment of Jeffrey Black as Senior Vice President and Chief Financial Officer effective today. Black will lead Standard BioTools' finance, accounting and investor relations functions, reporting to Michael Egholm, Ph.D., President and Chief Executive Officer. Vikram Jog will remain at the company for a period as Special Advisor to the CEO to ensure an effective transition. Black was most recently Chief Financial Officer at Apollo Endosurgery, Inc. until Apollo's acquisition by Boston Scientific (BSX) in April 2023.
|
SISXF | Hot Stocks07:46 EDT Savaria appoints Sebastien Bourassa as COO - Savaria announced the appointment of Sebastien Bourassa to the position of COO effective May 15, 2023. In this newly created role, Mr. Sebastien Bourassa will lead the daily global operations of the corporation including its 17 facilities for manufacturing and distribution in North America, Europe, China and Mexico. He will focus on the continued optimization of manufacturing operations and procurement activities, two core initiatives for Savaria that enhance integration synergies from key acquisitions made by the corporation in recent years. He will oversee all business segments to help meet sales and profitability targets, as well as help ensure that strategic initiatives are communicated and implemented across all divisions of Savaria, promoting a teamwork culture. His previous role at Savaria was Vice President of Operations and Integration.
|
MGDPF | Hot Stocks07:45 EDT Marathon Gold reports Q1 capex C$61M vs. C$13.4M last year - Cash and cash equivalents at March 31, 2023 of C$130 million. Reports Q1 net loss C$0.9M vs. C$3.8M last year. In the first quarter of 2023, 149,289 hours of work have been completed at the site with zero lost time incidents and zero reportable environmental incidents; 440 persons were employed directly or contracted to the Project. On the basis of voluntary declaration, 14% of the persons employed by the Company or contracted to the Project are female, 5% are Indigenous persons, 4% are visible minorities, 1% are persons with disabilities, 24% are residents of the six communities within Project's socio-economic area of influence and 72% are residents of the province of NL; Overall completion at the Project stood at 27% compared to a plan of 26%. Engineering progress stood at 71%, procurement at 51% and construction at 9%; 1.35 mtonnes of waste rock had been mined at the Leprechaun pit for construction purposes. In the month of March 2023, mining productivity has averaged 11,815 tonnes per day, successfully supporting ongoing civils work, including construction of haul roads and the Project's process plant site; and The Project remains on schedule for ore delivered to the mill by the end of 2024 and first gold in the first quarter of 2025.
|
MOND | Hot Stocks07:44 EDT Mondee announces acquisition of Consolid - Mondee announced the acquisition of Consolid Mexico Holding, S.A.P.I. de C.V., or Consolid, a high-growth, leading travel provider based in Mexico with a global presence and an emphasis in Latin America, LATAM. Headquartered in Mexico City, Consolid enjoys a global presence and clientele, with a focus on Mexico, the second largest market in Central and South America, as well as other countries in the region. Mondee's acquisition of Consolid supports continued expansion in LATAM as it comes on the heels of the acquisitions of Brazil-based Orinter in January 2023 and Interep in May 2023. Mondee's Chairman, CEO, and Founder, Prasad Gundumogula, stated, "We are thrilled to welcome Consolid's CEO Judith Guerra Aguijosa and experienced management team into the Mondee family and look forward to helping provide their customers with additional products and services. We have every confidence they will continue to grow the business actively within their markets. The recent acquisitions of Orinter, Interep and now Consolid, further reinforce Mondee's growing market presence in Brazil, Mexico, and throughout the Americas. Our strategy is to continue expanding our footprint in LATAM and other attractive global regions through the acquisition of businesses that complement and synergize with our existing solutions, thereby enhancing our expert-backed experiential content."
|
MOND | Hot Stocks07:43 EDT Mondee announces acquisition of Interep Representacoes - Mondee announced the acquisition of Interep Representacoes Viagens E Turismo S.A, a fast-growing, major B2B travel provider based in Sao Paulo, Brazil. The acquisition of Interep will further expand and diversify Mondee's geographic footprint in Latin America, enhance its product offerings, and provide a complementary distribution network to that of Orinter, given Interep's focus on the luxury market. The transaction is valued at $8.9million, with $4 million paid in cash at closing, $720,000 in cash over a three-year period, and 416,000 shares of Mondee stock, implying just over 3 times multiple of 2022 adjusted EBITDA, plus an additional earn-out to be paid over a three-year period, linked to increases in adjusted EBITDA. Mondee's Chairman, CEO, and Founder, Prasad Gundumogula, expressed excitement about welcoming Interep's all-female ownership team and expanding Mondee's presence in Latin America. He stated, "We are delighted to have Cynthia and Diana, Interep's accomplished management team, join the Mondee family. Our recent acquisitions of Orinter and now Interep advance our market presence in Brazil and the broader South American markets. Our strategy is to continue expanding our footprint in the region and other attractive global markets by acquiring businesses that complement and synergize with our existing solutions and enhance our expert-backed experiential content."
|
PDSB | Hot Stocks07:42 EDT PDS Biotechnology expects cash to fund programs into 3Q24 - Cash and cash equivalents as of March 31, 2023, totaled approximately $65.2 million. Based on the Company's cash resources with the anticipated initiation of one registrational trial in 2023, PDS Biotech believes this balance is sufficient to fund the Company's operations and research and development programs into the third quarter of 2024.
|
QURE | Hot Stocks07:42 EDT uniQure announces sale of royalty interest in HEMGENIX for up to $400M - uniQure announced it has entered into a definitive agreement to sell a portion of the royalty rights due to uniQure from CSL Behring from the net sales of HEMGENIX to HealthCare Royalty and Sagard Healthcare for a gross purchase price of up to $400 million in cash. "This attractive financing provides uniQure with immediate, non-equity-dilutive capital to continue to invest in our AAV gene therapy pipeline and platform and to advance potentially breakthrough gene therapies for patients, including AMT-130 in Huntington's disease, AMT-260 for refractory temporal lobe epilepsy, AMT-162 for SOD-1 ALS and other product candidates," stated Matt Kapusta, chief executive officer of uniQure. "The partial monetization of this royalty stream validates the significant potential of HEMGENIX global sales while substantially reducing commercialization risk for uniQure. We are pleased to reach this agreement with HealthCare Royalty and Sagard Healthcare, each of whom is a recognized leader in funding innovation across life sciences, and look forward to furthering our opportunities for growth and value creation." Under the terms of the agreement, uniQure will receive an upfront cash payment of $375 million in exchange for the lowest royalty tier on CSL Behring's worldwide net sales of HEMGENIX(R) up to 1.85 times the purchase price until June 30, 2032 or, if such cap is not met by June 30, 2032, up to 2.25x the purchase price through December 31, 2038. uniQure also is eligible to receive an additional $25 million milestone payment if 2024 net sales of HEMGENIX(R) exceed a pre-specified threshold. uniQure will retain the rights to all other royalties under its existing Commercialization and License Agreement with CSL Behring, as well as contractual milestones totaling up to $1.5 billion, including the $100 million milestone for the first U.S. product sale and the $75 million milestone for the first product sale in one of five major European countries if achieved prior to July 2, 2023. The transaction is expected to close no later than 15 business days from signing.
|
VIRI | Hot Stocks07:40 EDT Virios announces submission of final toxicology results for Phase 3 proposal - Virios Therapeutics announced that it has submitted final toxicology reports as per Food & Drug Administration request as part of their overall review of the Company's Phase 3 proposal. Highlights: Proposed Phase 3 program for lead development candidate IMC-1 to the FDA as treatment for FM consisting of four primary components: two adequate and well-controlled clinical studies, one of which would be a full factorial design with each of the individual components of IMC-1 as separate comparator arms, a long-term safety trial, and a pharmacokinetic/food effect study. Based on data from its recently completed FORTRESS Phase 2b trial, the Company proposed a Phase 3 development program targeting community-based FM patients, who have not participated in prior FM trials. "We are pleased to report that we have submitted the final toxicology program results in support of our proposal to advance IMC-1 to Phase 3 development," said Greg Duncan, Chairman and CEO of Virios Therapeutics. "We will report material FDA feedback on our Phase 3 proposal promptly, as we receive it."
|
RCFA | Hot Stocks07:40 EDT RCF Acquisition announces results of shareholder redemptions - RCF Acquisition Corp. announced that each of the proposals submitted at its extraordinary general meeting in lieu of annual meeting of shareholders, which was held on May 9, 2023, were approved. At the Extraordinary General Meeting, RCFA sought shareholder approval to, among other things, extend the time it has to consummate an initial business combination from May 15, 2023 to May 15, 2024. After taking into account the number of shares that were submitted for redemption, the Company expects to have approximately $136.7 million remaining in its trust account established in connection with its initial public offering. As previously announced, on March 14, 2023, RCFA signed a non-binding letter of intent for a business combination with a company in the critical minerals sector. RCFA continues to work diligently toward consummating an initial business combination by the Extended Date. However, no assurances can be made that RCFA and Target will successfully negotiate and enter into a definitive agreement regarding a business combination or that RCFA will be able to consummate an initial business combination by the Extended Date. Any transaction would be subject to board and equity holder approval of both companies, regulatory approvals and other customary closing conditions
|
TGI | Hot Stocks07:40 EDT Triumph Group awarded multi-year contract from ITP Aero - Triumph Group's Product Support business in Grand Prairie, Texas has been awarded a multi-year contract with ITP Aero, a tier one engine Original Equipment Manufacturer, to provide Maintenance, Repair and Overhaul support on accessory components including propeller gearboxes, hydromechanical units, oil scavenge and fuel boost pumps, anti-icing and overspeed drain valves. ITP Aero, headquartered in Zamudio, Spain, is in the aeronautical and industrial engines market, involved in all phases of the product life cycle, all the way from the design phase to support and maintenance.
|
DORM | Hot Stocks07:39 EDT Dorman Products launches hundreds of products, dozens of repair solutions - Dorman Products announced the release of almost 200 new motor vehicle parts, more than a third of which are aftermarket-exclusive repair solutions. The new products provide repair professionals and owners greater freedom to fix motor vehicles and expand revenue and profit opportunities for Dorman's retailers and distributors. This month's new releases include a first-to-the-aftermarket suspension sway bar bracket kit designed to fit more than one million 2011-2015 Jeep Grand Cherokee and Dodge Durango SUVs on the road today. When the sway bar bushings fail on those popular vehicles, the dealer solution is to offer a complete sway bar assembly. The new Dorman OE FIX suspension sway bar bracket kit is designed to be installed on the factory sway bar, saving labor and expense on its initial installation and during future sway bar bushing replacements. The kit contains a pair of sturdy top and bottom mounting brackets, two premium quality split bushings, and the hardware needed for the swap that helps eliminate future sway bar repair hassles.
|
PNT | Hot Stocks07:38 EDT Point Biopharma announces collaboration with IONETIX Corporation - POINT Biopharma Global and IONETIX Corporation announced a collaboration to create Ionetix Alpha. Ionetix-, a new subsidiary of IONETIX, is focused on near-term, commercial-scale production of Good Manufacturing Practice, GMP, grade therapeutic isotopes, such as actinium-225. "Access to GMP grade therapeutic isotopes like 225Ac continues to be a key rate-limiting factor in the clinical development of next generation radioligands," said Dr. Joe McCann, Chief Executive Officer of POINT. "With this investment, POINT is demonstrating its ongoing commitment to overcoming the barriers that have historically limited radioligand development, positioning us uniquely in this emerging high potential therapeutic modality." IONETIX has transferred its alpha therapy isotope business assets into Ionetix-. POINT will invest $10M into Ionetix-. Ionetix- will initially produce and distribute 225Ac from its isotope production and manufacturing facility located in Lansing, Michigan. This first-of-its kind facility is highly specialized and dedicated exclusively to the production and distribution of alpha-emitting radionuclides using cyclotrons. The first of two cyclotrons have been installed and commissioned.
|
BCBNF | Hot Stocks07:37 EDT Base Carbon reports total assets of $43.1M as of March 31 - As at March 31, 2023, the Company had $0.3 million in current liabilities, which represented the total liabilities for the Company. During the first-quarter ended March 31, 2023, the Company incurred a net loss of $1.1 million. The Company incurred operating expenses of $1.3 million, which are mainly attributable to salaries and wages, share-based compensation, consulting, and professional fees.
|
LRMR | Hot Stocks07:36 EDT Larimar Therapeutics reports topline data from Phase 2 trial's 25 mg cohort - Larimar Therapeutics announced preliminary top-line data from the 25 mg cohort of its Phase 2, four-week, placebo-controlled, dose exploration trial of CTI-1601 in participants with Friedreich's ataxia. Participants in the trial's 25 mg cohort were randomized to receive subcutaneous injections of 25 mg CTI-1601 or placebo daily for 14 days and then every-other-day thereafter until day 28. Data from the cohort indicate CTI-1601 was generally well tolerated and showed increases in frataxin levels from baseline compared to placebo in all evaluated tissues at day 14. In skin, a median placebo-adjusted increase from baseline of 3.5 pg/microgram in frataxin levels was observed on day 14. Of the seven CTI-1601-treated participants with quantifiable levels of frataxin in skin at both baseline and day 14, all seven had increases in skin frataxin concentrations, compared to none of the four placebo participants with quantifiable levels of frataxin in skin at both baseline and day 14. In buccal cells, a median placebo-adjusted increase from baseline of 0.9 pg/microgram in frataxin levels was observed on day 14. Of the seven CTI-1601-treated participants with quantifiable levels of frataxin in buccal cells at both baseline and day 14, five had increases in buccal cell frataxin concentrations, compared to neither of the two placebo participants with quantifiable levels of frataxin in buccal cells at both baseline and day 14. In a non-interventional study that used the same sampling technique and assay as Larimar's Phase 2 trial to measure frataxin levels in 60 homozygous healthy volunteers, median frataxin concentrations observed in skin and buccal cells were 16 pg/microgram and 8 pg/microgram, respectively. Larimar therefore estimates phenotypically healthy heterozygous carriers of the FA-causing gene to have median frataxin concentrations of approximately 8 pg/microgram and 4 pg/microgram in skin and buccal cells, respectively, based on published literature indicating heterozygous carriers have frataxin levels that are approximately 50% of those of homozygous healthy people. Larimar's Phase 2 data and non-interventional study results follow Phase 1 data that showed dose-dependent increases in frataxin levels in peripheral tissue with daily dosing of 50 and 100 mg of CTI-1601 for at least 7 days, and no detectable increase in FXN levels with daily dosing of 25 mg of CTI-1601 for only 4 days. Larimar has submitted the data from the trial's 25 mg cohort to FDA and has a meeting scheduled with the Agency for later this quarter to discuss the information needed to gain clearance to initiate a 50 mg cohort in the Phase 2 trial.
|
THRN | Hot Stocks07:35 EDT Thorne HealthTech enters into R&D partnership with Arome Science for test - Thorne HealthTech is entering into a research and development partnership agreement with Arome Science, a leader in metabolomics, to develop a next-generation metabolomics test. Arome Science and Thorne will collaborate to develop a commercial metabolomics wellness test. The test will be used to support research studies using at-home blood collection via Thorne's OneDraw medical device. The metabolomics test will be further developed and validated for an eventual offering in the consumer space.
|
ILMN IEP | Hot Stocks07:35 EDT Illumina board urges shareholders to vote the WHITE proxy card - Illumina's Board of Directors requests that shareholders protect the value of their investment and future of the company by voting the WHITE proxy card today FOR all nine of the company's highly qualified director nominees and not for Carl Icahn's unfit three associates. The Annual Meeting will be held on May 25, 2023, at 10:00 am Pacific Time (1:00 pm Eastern Time). Shareholders of record as of close of business on April 3, 2023, are entitled to vote at the meeting, no matter how many or how few shares they own. Reference Link
|
AVTR | Hot Stocks07:33 EDT Avantor CFO Thomas Szlosek to leave company effective August 2 - Avantor announced that Executive Vice President and CFO Thomas Szlosek will be leaving the company effective August 2 to pursue an opportunity outside the life sciences industry. Szlosek will continue in his role through the announcement of the company's second quarter earnings. Avantor has initiated a search to identify the company's next CFO. The company reaffirmed the fiscal 2023 financial guidance provided during the first quarter earnings conference call on April 28.
|
ASLN | Hot Stocks07:33 EDT Aslan Pharmaceuticals presents new data on Eblasakimab, Farudodstat - ASLAN Pharmaceuticals announced the presentation of new eblasakimab and farudodstat data in late-breaker oral and poster presentations respectively, at the 1st International Societies for Investigative Dermatology meeting, which took place from May 10 to 13, 2023, in Tokyo, Japan. 2023 ISID late-breaker poster details: Eblasakimab: "Downstream effects of IL-13alpha1 blockade on Type 2 inflammation and Th1 immune axis activation in atopic dermatitis." Current evidence indicates that the pathogenesis of AD involves two critical cytokines, IL-4 and IL-13, which mediate type 2 helper T cell-driven inflammation through the Type 1 receptor and Type 2 receptor. The contributions of Type 1 and Type 2 signalling in driving Th2 inflammation are currently unknown and hence we have yet to understand the most effective way to inhibit Th2 inflammation in patients with AD. This study evaluates the effect of blocking either both Type 1 and Type 2 receptors signalling, using anti-IL-4Ralpha antibody, or only Type 2 receptor signalling using eblasakimab, a monoclonal antibody that binds IL-13Ralpha1. IL-13Ralpha1 blockade with eblasakimab was associated with statistically significant lower levels of Th2-key cytokines including TARC, IL-13, IL-4 and MCP-4 compared to blockade of IL-4Ralpha. Furthermore, the activation of Th1 cytokines, including TNF-alpha, IL-2, GM-CSF, IL-12 and IP-10, was significantly increased with anti-IL-4Ralpha treatment as compared to eblasakimab treatment. Collectively, the data indicates that selective targeting of the IL-13Ralpha1 with eblasakimab may lead to a more potent control of Th2 inflammatory response while dampening Th1 activation compared to targeting IL-4Ralpha. Farudodstat: A novel ex vivo model of human hair follicle immune privilege collapse reveals the potential of farudodstat, a DHODH inhibitor, as a therapeutic for alopecia areata treatment. Our novel ex vivo model used microdissected HFs from healthy human donors stimulated with anti-CD3/CD28 antibodies to promote intra- and peri-follicular T-cell activation. When anti-CD3/CD28 was applied to healthy HFs there was 1) an increase in CD3+ and CD3+ Ki-67+ in the epithelium and mesenchyme, indicative of T cell activation and proliferation 2) increased expression of key markers MHC I and II proteins which revealed loss of IP. Subsequent treatment with farudodstat significantly reduced the proliferation of T-cells, decreased MHC expression and the number of MHC-II+ cells in the hair bulb, suggesting potential protection from IP loss. Farudodstat alone did not affect hair matrix keratinocyte proliferation or IP markers, suggesting no signs of cytotoxicity were observed in healthy HFs. Together, the findings highlight the potential for farudodstat as a novel therapy for AA.
|
BKBEF | Hot Stocks07:32 EDT Pipestone Energy curtails 20,000 boe/d of production amid wildfires - Pipestone Energy advises that its operations in the Grande Prairie area are again being impacted by the ongoing wildfires. As a result of the precautionary shut-in of certain third-party infrastructure and associated operated producing locations, approximately 20,000 boe/d of production has been temporarily curtailed since the evening of May 12, 2023. From May 8th to May 12th, Pipestone had restarted the majority of its producing assets until the resurgence of wildfires in proximity to certain third-party processing facilities. The Company is not aware of any significant damage or loss to either its owned or third-party infrastructure. While timing remains uncertain, Pipestone is ready to resume production as soon as the currently shut down third party infrastructure is restarted. Pipestone will provide further updates to the market as the situation unfolds.
|
AOTVF | Hot Stocks07:28 EDT Ascot Resources provides 2023 outlook - With the financing package closed on January 19, 2023, the Company believes that it has sufficient funding to complete construction of the Project and achieve first gold production in early 2024. The key activities for 2023 include: During Q1 2023, contractors were re-mobilized to the mill and significant progress has been made since then in the area of mechanical installation, piping, electrical and related surface infrastructure; Construction of the process plant and associated surface infrastructure such that the plant is expected to be in pre-commissioning by the end of 2023; Completion of the tailings dam improvements and start up of the new water treatment plant by Q4 2023, and in order to facilitate the dewatering of the tailing dam for construction, a temporary water treatment plant has been installed and dewatering activities are planned for the month of May, June and July 2023; Advancement of the PNL portal and underground development and additional underground development of the Big Missouri mine; Maintaining a Health and Safety record of zero lost time incidents and achieving the 2023 goals outlined in the Company's 2022 Sustainability Report; Advancing the recruitment of site personnel in line with the site personnel plan by the end of 2023; Maintaining permitting and environmental compliance so that there are no delays in the project construction schedule; More exploration and infill drilling north and west of existing resources
|
WT | Hot Stocks07:27 EDT ETFS Capital highlights 'value destruction' of WisdomTree's board - ETFS Capital Limited, the largest combined owner of common stock and Series A Non-Voting Convertible Preferred Stock of WisdomTree, with ownership of approximately 10.2% of the outstanding Common Stock, which together with its Series A Preferred Stock would represent approximately 18.3% of the Company's outstanding Common Stock on an as-converted basis, commented today on the WisdomTree board of director's latest distraction tactics and desperate smears against its largest stockholder contained in a letter to stockholders on May 12, 2023. "ETFS Capital will not indulge the Board in its desire for an exchange of mudslinging and personal attacks. Instead, as responsible fiduciaries of our investment in WisdomTree, we present the following facts for our fellow stockholders to consider: $1 billion of Value Destroyed by an Entrenched Board: Since the sale of its European ETC business to WisdomTree in November 2017, ETFS Capital has watched the Board preside over the destruction of $1 billion of stockholder value.... ETFS Capital Played a Critical Role in Resolving the Gold Payable Obligations and Unlocking Value....The Board is not Serious About Renewal or Stockholder Representation on the Board... The Board is Attempting to Distract Stockholders by Mischaracterizing Routine Commercial Dealings...WisdomTree's CEO's Recent Statements and Behavior Should be Troubling to All Stockholders: ETFS Capital encourages stockholders to listen to the Company's investor call held on May 10, 2023 to discuss the resolution of the gold payable obligation, and reflect on the seemingly unprofessional demeanor and haphazard comments made by CEO Jonathan Steinberg," ETFS Capital said.Reference Link
|
FPI | Hot Stocks07:25 EDT Farmland Partners sells 2,426 acres for gain on sale of $31M - Farmland Partners announced that it sold 2,426 acres of farmland in Nebraska and South Carolina to the tenants who rented the properties. The transactions totaled $16.2M and represented a total gain on sale of more than $3.1M, or approximately 24% over net book value. "These transactions highlight the appreciation power of farmland, as well as the health of the farm economy in general. The proceeds from these asset sales are being used to generate value for our shareholders, reducing indebtedness and buying back stock at a discount to our estimate of its value," said Luca Fabbri, FPI's President and CEO. "Additional dispositions will be forthcoming, but we continue to look for smart additions for our portfolio as well." The Company also completed two property dispositions for $7.1M and a total gain on sale of $1.8M in the quarter ending March 31.
|
OXBDF | Hot Stocks07:24 EDT Oxford Biomedica launches TetraVecta lentiviral vector system - Oxford Biomedica announces the launch of its 4th generation lentiviral vector delivery system, TetraVecta. This technology developed at Oxford Biomedica elevates the quality, potency and packaging capacity of lentiviral vectors, while incorporating new and enhanced safety features, adding to the Company's client offering and its leading LentiVector platform. The TetraVecta system significantly enhances the development and manufacture of safer and more effective lentiviral vector-based therapies. This enables cell and gene therapy companies to overcome previous barriers in therapeutic development, due to the size, complexity, or interference of the payload to be delivered. This cutting-edge new technology paves the way for genuine plug and play manufacturing and supports Oxford Biomedica's clients in delivering their innovative and life-changing treatments to patients. The features of the TetraVecta system can also be used to accelerate the development and adoption of in vivo gene therapies. In addition to its broad applications, the TetraVecta system has demonstrated its versatile potential by supporting the creation of high-titre stable producer cell lines for previously unachievable payloads such as Chimeric Antigen Receptor constructs for CAR-T therapy.
|
FSR | Hot Stocks07:23 EDT Fisker commencing next phase of production of Fisker Ocean SUV - "Fisker is commencing the next phase of production as it accelerates its global launch of the electric Fisker Ocean SUV, and is planning to deliver to next customers across Europe and US markets starting in June. As previously announced, Fisker expects to gradually ramp up production over the course of May and plans to build 1,400-1,700 vehicles by end of June, provided all partners deliver.1 The company plans to increase production further during Q3 2023 to support the delivery roll-out in the rest of its global launch markets and support its 2023 volume forecast of 32,000-36,000 vehicles. "Consistent with our brand's commitment, we are going to give extra attention to detail on each vehicle ensuring a great customer experience, since these are built for our first volume deliveries and marketing purposes such as test drives," says CEO Henrik Fisker. "I am excited about our next customers' deliveries coming up, and we will inform our first customers shortly on timing as we are finalizing the schedule now." Fisker is beginning to gradually ramp-up production while working with the supply chain to ensure all are capable of meeting the brand's volume and quality expectations.1 Included in the Fisker Ocean Ones to be produced in May are the first US-bound units for customer deliveries and marketing purposes, which are expected to start arriving in June," said the company in a statement.
|
BWEN | Hot Stocks07:21 EDT Broadwind announces ISS, Glass Lewis recommends vote 'FOR' all nominees - Broadwind announced that leading proxy advisory firms, Institutional Shareholder Services and Glass, Lewis & Co., have both recommended Broadwind stockholders vote on the Company's WHITE proxy card in favor of all seven of Broadwind's director nominees, as well as all other management proposals, at the upcoming 2023 annual meeting of stockholders scheduled to be held on May 23, 2023. In its report, ISS notes the following: "BWEN has already booked its first win in this new environment, announcing the largest tower order in company history in January. The market has reacted positively to the order, operational performance has since been promising, and the analyst community has expressed a generally favorable outlook for BWEN's prospects." "The dissident has presented a critique that amounts to a one-dimensional observation of historical underperformance. The critique overlooks recent developments, emphasizes legacy deficiencies that are detached from the present state of affairs, and generally fails to establish a cohesive argument." "The dissident has not made a compelling case for change. As such, votes FOR all seven management nominees are recommended." In its report, Glass Lewis notes the following: "We believe the future appears bright at the Company, evidenced not least by the recently announced Tower Order, with management and research analysts expecting strong performance and a return to profitability in 2023 and continuing through 2024." "The Company Nominees are the most suitable candidates to lead Broadwind through what appears to be the beginning of an emergence from the industry downturn in the wake of the pandemic." "Broadwind welcomes the favorable recommendations from ISS and Glass Lewis following deep analysis of the Company," stated Eric Blashford, President and CEO of Broadwind. "These recommendations reinforce our belief that the Company is heading in the right direction under its current leadership."
|
SRPT | Hot Stocks07:20 EDT Sarepta jumps 26% to $150.96 following positive FDA panel vote
|
FULC | Hot Stocks07:19 EDT Fulcrum Therapeutics expects cash to fund operations into mid-2025 - Fulcrum expects that its existing cash, cash equivalents, and marketable securities will be sufficient to fund its operating expenses and capital expenditure requirements into mid-2025.
|
BRTX | Hot Stocks07:18 EDT BioRestorative Therapies receives notice of allowance for patent in Japan - BioRestorative Therapies announced that the Japanese Patent and Trademark Office has issued a notice of allowance for a patent application related to the Company's metabolic ThermoStem program. The notice of allowance was issued on May 8, 2023. Upon issuance, this will be the fourth patent granted in Japan for the ThermoStem program. Claims granted under the new Japanese patent will cover implantable three-dimensional scaffolds and brown adipocytes that have been derived from human brown adipose-derived stem cells. Therapeutic benefits of using brown adipose have been demonstrated in various models and may provide a valuable therapeutic tool for treating a range of metabolic disorders.
|
FULC | Hot Stocks07:17 EDT Fulcrum Therapeutics appoints Sapir as CEO - Fulcrum Therapeutics announced the appointment of Alex Sapir as chief executive officer and president, effective July 1st, 2023. Upon assuming his new role, Sapir will also join Fulcrum's board of directors. Interim CEO and president, Robert Gould Ph.D., will continue to serve as a member of the board of directors following the transition. Sapir joined Fulcrum as special advisor to the interim president and CEO in a part-time capacity before assuming his new role. Effective with the commencement of his employment, Fulcrum granted Sapir an inducement award under Fulcrums' 2022 Inducement Stock Incentive Plan on May 12, 2023, as an inducement material to his entry into employment with Fulcrum in accordance with Nasdaq Listing Rule 5635(c)(4).
|
LNZA | Hot Stocks07:17 EDT LanzaTech expects to reach positive adjusted EBITDA by end of 2024 - As of March 31, 2023, LanzaTech had $194.9 million in cash, cash equivalents, restricted cash, and investments in US Treasuries compared to the $83.7 million of cash and investments at the end of 2022. LanzaTech does not have any outstanding debt, other than the Brookfield SAFE and the Fixed Maturity Consideration, as described in the Company's filing on Form 10-Q for the quarter ending March 31, 2023, which, for accounting purposes, is treated as a debt instrument and is classified as a liability on the Company's condensed consolidated balance sheet as of March 31, 2023. The Company believes that the current liquidity resources will be sufficient for it to reach positive adjusted EBITDA by the end of 2024.
|
PBTHF | Hot Stocks07:15 EDT PointsBet to sell U.S. assets to Fanatics Betting and Gaming for $150M in cash - PointsBet announced that it has entered into a stock and equity sale agreement for the sale of its United States sports wagering, advanced-deposit wagering, or ADW, and iGaming operations, Banach technology, and a copy of the software for, and a license to use , the company's proprietary technology platform, to FBG Enterprises Opco, LLC d/b/a Fanatics Betting and Gaming, or FBG, for headline cash consideration of $150M on a "cash free, debt free" basis, subject to shareholder approval and certain regulatory and other conditions. The company will retain its Australian business and operations and its Canadian business and operations. The company will also retain its proprietary sports wagering, racing and iGaming platform and be granted a perpetual, royalty-free license to exploit the Banach technology assets. On completion the company will be able to continue to exploit both platforms in all geographic regions, except in the U.S. for an 18-month period. The company will retain its outstanding teams in Australia, Canada and India. PointsBet's funding requirement for the US Business will be capped at approximately $21M from the conclusion of the shareholder meeting to final completion of the proposed transaction. As part of the arrangements agreed, PointsBet will provide services to FBG prior to the final closing of the deal and be reimbursed for the cost of these services by FBG. For the avoidance of doubt, PointsBet's commercial commitments to NBCUniversal are to be transferred in full to FBG as part of the proposed transaction. PointsBet's final payment to NBCUniversal is included as part of its capped funding requirement. NBCUniversal has also released PointsBet Holdings Limited from its guarantee obligations under its Media Services Agreement from final Completion, and has irrevocably waived its right to exercise the equity options previously issued. These options have been terminated. If the proposed transaction completes, the company intends to distribute to shareholders the net sale proceeds together with the majority of the company's corporate cash reserves that will be surplus to the needs of the remaining business. The board currently estimates this distribution of capital to be approximately A$1.07 to A$1.10 per share, in total. The distribution of capital is expected to be made over two tranches in-line with the two-stage completion process. PointsBet shareholders will vote on the proposed transaction at a shareholder meeting expected to be held in late June. The PointsBet board unanimously recommends that shareholders vote in favor of the proposed transaction at the shareholder meeting, in the absence of a superior proposal.
|
GRCL | Hot Stocks07:14 EDT Gracell begins study of GC012F in Lupus Erythematosus - Gracell Biotechnologies announced the initiation of an investigator-initiated trial in China of GC012F, the company's autologous FasTCAR therapeutic candidate dual-targeting B cell maturation antigen and CD19, for the treatment of refractory Systemic Lupus Erythematosus, or SLE. SLE is a chronic autoimmune disease, in which the autoantibodies produced by the immune system attack the patient's own tissues, causing multi-organ damage. SLE is a new therapeutic area of interest for Gracell, as CD19 CAR-T has been reported in recent clinical research to be potentially "feasible, tolerable, and highly effective in this indication". No neurotoxicity or immune effector cell-associated neurotoxicity syndrome has been observed in any patients treated across three studies. 75% of patients in the NDMM study has not experienced cytokine release syndrome of any grade, and in the RRMM study, patients experienced mostly low-grade CRS. The FasTCAR next-day manufacturing platform technology could bring additional benefits to SLE patients as it shortens patient wait time, enhances CAR-T cell fitness, and reduces costs.
|
CSIQ... | Hot Stocks07:10 EDT Canadian Solar subsidiary signs aggregation deal for 100MW in Texas - Canadian Solar's (CSIQ) wholly owned subsidiary Recurrent Energy has signed an aggregated virtual power purchase agreement with EMD Electronics, Biogen (BIIB), Wayfair (W), Autodesk (ADSK) and a large healthcare company for 100% of the production capacity of the Liberty Solar project. Recurrent Energy is currently developing the 100 MWac solar project in Liberty County, Texas, around 50 miles from Houston. The project is expected to be operational in 2024. EMD Electronics, the U.S. and Canada electronics business of Merck , Darmstadt, Germany, will purchase renewable energy generated by a 40 MW portion of Liberty Solar, serving as the anchor buyer of the project. Once operational, Liberty Solar will help achieve Merck (MRK), Darmstadt, Germany's goal to match 80% of the globally purchased electricity from renewable sources by 2030 and become climate neutral by 2040. Biogen will purchase renewable energy generated by a 20 MW portion of Liberty Solar as part of its commitment to 100% renewable electricity. Wayfair will purchase renewable energy generated by a 15 MW portion of Liberty Solar. Once the project is online, Wayfair's portion is expected to produce 37,000 MWh. Autodesk will purchase renewable energy generated by a 10 MW portion of Liberty Solar. A large healthcare company will purchase renewable energy generated from the remaining 15 MW portion of Liberty Solar. The five companies were organized and supported by Sustainability Roundtable's Net Zero Consortium for Buyers, the leading platform for corporate aggregated procurement of large-scale renewable energy in the U.S. and Europe.
|
ZYNE | Hot Stocks07:10 EDT Zynerba expects cash to fund operations to mid-year 2024 - As of March 31, 2023, cash and cash equivalents were $44.4 million, compared to $50.6 million as of December 31, 2022. On May 11, 2021, the Company entered into a Controlled Equity OfferingSM Sales Agreement, with Cantor Fitzgerald & Co., Canaccord Genuity, LLC, H.C. Wainwright & Co. LLC and Ladenburg Thalmann & Co. Inc., as sales agents, pursuant to which the Company may sell, from time to time, up to $75.0 million of its common stock. We are currently subject to General Instruction I.B.6 of Form S-3, and the amount of funds we can raise through primary public offerings of securities in any twelve-month period using our existing registration statement on Form S-3 is limited to one-third of the aggregate market value of the voting and non-voting common equity held by non-affiliates. We will be subject by this limit until such time as our public float exceeds $75.0 million. In the first quarter of 2023, the Company sold and issued 1,179,077 shares of its common stock under the 2021 Sales Agreement in the open market resulting in gross proceeds of $0.7 million and net proceeds of $0.6 million, after deducting commissions and offering expenses. On July 21, 2022, the Company entered into a Purchase Agreement and registration rights agreement for up to $20.0 million with Lincoln Park Capital Fund, a Chicago-based institutional investor. In the first quarter of 2023, the Company sold and issued 2,100,000 shares of its common stock under the 2022 Purchase Agreement resulting in gross and net proceeds of $1.1 million. From April 1, 2023 through May 11, 2023, the Company sold and issued 150,000 shares of common stock under the Purchase Agreement resulting in gross and net proceeds of $0.1 million. Management believes that the Company's cash and cash equivalents are sufficient to fund operations and capital requirements to mid-year 2024. Top-line results from the Company's confirmatory pivotal Phase 3 RECONNECT trial of Zygel in patients with FXS are expected in the first half of 2024.
|
TRVN | Hot Stocks07:07 EDT Trevena expects cash to fund requirements through 2023 - Cash, cash equivalents and marketable securities were $27.4 million as of March 31, 2023, which the Company believes will be sufficient to fund the Company's operations through year-end 2023. Together with the expected $3 million Nhwa Milestone payment and $15 million available under the R-Bridge Financing upon Nhwa's first commercial sale of OLINVYK in China, the Company believes this will be sufficient to fund operations to mid-2024.
|
MIND | Hot Stocks07:05 EDT MIND Technology announces $3.1M source control order - MIND Technology announced that its Seamap unit has received an additional order for a GunLink source control system for delivery later this fiscal year. The order has a total value of approximately $3.1M.
|
FRBK | Hot Stocks07:04 EDT Republic First Bancorp says bank has 'adequate capital position' - Republic First Bancorp provided the following updates. Based on the positive impact associated with new leadership's initial strategic initiatives and other considerations, the Company's Board of Directors has determined that the Bank has an adequate capital position at this time. The Company's recent initiatives include winding down both its New York City commercial lending business and mortgage origination business. These steps were taken to improve efficiency in the near-term and support profitable growth within core service markets over the long-term. In the coming weeks and months, new leadership intends to implement additional initiatives to advance its strategic realignment of the Bank. On March 10, 2023, the Company announced a $125 million capital raise - which included commitments from seasoned community bank investor Castle Creek Capital and an affiliate of Cohen Private Ventures, LLC - that requires the participation of additional accredited investors. The Board has decided to wait for market conditions to stabilize before identifying additional participants to round out the capital raise on acceptable terms. Prior to reaching its determination, the Board worked with independent legal and financial advisors to evaluate the Bank's near-term capital needs in the context of the recent market dislocation and in keeping with its duties. Thomas Geisel, President and CEO, stated: "The actions we have taken - and will continue to take - are laying the foundation for a more efficient, profitable business that can create enhanced value for all shareholders and stakeholders. While recent initiatives are already having a positive impact, they are just the first steps in our strategic realignment of the Bank. We remain focused on taking actions to preserve the Bank's capital, strengthen our core business, and position us to identify additional investor commitments at the right time and on the right terms. Protecting Republic's valued shareholders from excessive and unnecessary dilution is very important to us."
|
ANIP | Hot Stocks06:52 EDT ANI Pharmaceuticals granted FDA approval for two ANDAs - ANI Pharmaceuticals received FDA approval for the Abbreviated New Drug Applications for Methsuximide Capsules USP, 300 mg and Alendronate Sodium Oral Solution 70 mg. Methsuximide Capsules has been granted 180-day Competitive Generic Therapy - CGT - Exclusivity, and Alendronate Sodium Oral Solution is eligible for CGT Exclusivity upon launch. ANI's Methsuximide Capsules are the generic version of the Reference Listed Drug Celontin Capsules and ANI's Alendronate Sodium Oral Solution is the generic version of the RLD Fosamax Oral Solution. The current annual U.S. market for Methsuximide Capsules and Alendronate Sodium Oral Solution is approximately $6.3M, according to IQVIA, a leading healthcare data and analytics provider.
|
DCBO | Hot Stocks06:41 EDT Docebo authorizes normal course issuer bid - Docebo announced that the Toronto Stock Exchange has approved its notice of intention to make a normal course issuer bid for a portion of its common shares. Docebo is authorized to acquire up to a maximum of 1,650,672 of its Shares, or approximately 5% of total shares outstanding as of May 1, 2023, for cancellation over the next 12 months. The number of Shares that can be purchased pursuant to the NCIB is subject to a current daily maximum of 10,924 Shares. Docebo may begin to purchase Shares on or about May 18, 2023 and the bid will terminate on May 17, 2024 or such earlier time as Docebo completes its purchases pursuant to the bid or provides notice of termination. Docebo intends to fund the purchases out of its available cash. Docebo may elect to suspend or discontinue its NCIB in accordance with certain conditions set forth in the Plan. The Plan will be effective as of May 18, 2023.
|
VET | Hot Stocks06:34 EDT Vermilion Energy restores 60% of production impacted by wildfires - Vermilion Energy reported that it has restored approximately 60% of the 30,000 boe/d of production that was temporarily shut-in as a result of the wildfires in West Central Alberta. We have inspected all of our key assets and confirm that there was no major damage to our facilities or well sites, and we will bring the remaining curtailed production back online as soon as it is safe to do so. As a result of this production being temporarily offline, we now expect Q2 production to average 80,000 to 83,000 boe/d. The company's 2023 annual production guidance of 82,000 to 86,000 boe/d remains unchanged.
|
TPG | Hot Stocks06:32 EDT TPG to acquire Angelo Gordon in $2.7B cash and equity transaction - TPG and Angelo Gordon announced that the companies have entered into a definitive agreement under which TPG will acquire Angelo Gordon in a cash and equity transaction valued at approximately $2.7B, based on TPG's share price as of May 12, 2023, including an estimated $970M in cash and up to 62.5M common units of the TPG Operating Group and restricted stock units of TPG, in each case, subject to certain adjustments. The transaction also includes an earnout based on Angelo Gordon's future financial performance, valued at up to $400M. The transaction is subject to customary closing conditions, including HSR, international regulatory approvals, and other client and third-party consents. The transaction, which was unanimously approved by the TPG Board of Directors, is expected to close in Q4 2023.
|
VNTR | Hot Stocks06:04 EDT Venator Materials to enter Chapter 11 process - Venator Materials announced that it has reached an agreement with the overwhelming majority of its lenders and noteholders on the terms of a recapitalization plan. The agreement will equitize nearly all of the company's funded debt, strengthen its balance sheet and facilitate an infusion of new capital, which will position the company for future growth and success. The recapitalization will be implemented through a prepackaged Chapter 11 process in the United States and will be financed by a debtor-in-possession, or DIP, financing facility, which includes a commitment for $275M in new-money financing from the company's supporting creditors. Following approval by the court, the DIP financing, together with cash on hand and cash generated from ongoing operations, is expected to provide liquidity to support Venator throughout the recapitalization process and beyond. Venator's businesses are expected to continue to operate as normal for the duration of the process, and Venator expects to continue to pay wages and benefits to its global workforce, and to pay all trade partners in the ordinary course. Throughout the court-supervised Chapter 11 process, Venator will remain in possession and control of its assets, retain its existing management team and board of directors, and gain access to the array of tools available under Chapter 11 to position the company for long-term sustainable growth. Venator commenced solicitation for votes on its prepackaged Chapter 11 plan, and expects to complete its Chapter 11 process within approximately two months. Venator expects to be delisted by the New York Stock Exchange in accordance with its rules. Venator common shares will, however, continue to trade in the over-the-counter marketplace throughout the duration of the Chapter 11 process. The shares are proposed to be cancelled as part of Venator's restructuring.
|
TSLA | Hot Stocks05:50 EDT Tesla recalling 1.1M cars in China over potential safety risks, regulator says - Tesla will recall more than 1.1M cars in China due to potential safety risks, China's State Administration for Market Regulation said in a statement. "Starting from May 29, 2023, some imported Model S, Model X, Model 3 and domestically produced Model 3 and Model Y vehicles with a production date between January 12, 2019 and April 24, 2023 will be recalled, totaling 1,104,622 vehicles," the regulator said. It added: "The vehicles within the scope of this recall do not allow the driver to choose the energy recovery braking strategy; at the same time, there may not be enough reminders for the driver to depress the accelerator pedal deeply for a long time. The superposition of the above factors may increase the probability of mistakenly stepping on the accelerator pedal for a long time, which may increase the risk of collision and pose a safety hazard." Reference Link
|
ADI | Hot Stocks05:14 EDT Analog Devices invests EUR 630M in European headquarters - Analog Devices announced a new EUR 630M investment at its European regional headquarters in the Raheen Business Park in Limerick, Ireland. The investment enables the construction of a new, state-of-the-art, 45,000 sq-ft Research & Development and manufacturing facility. The new facility will support ADI's development of next-generation signal processing innovations designed to accelerate the digital transformation of Industrial, Automotive, Healthcare, and other sectors. It is expected to triple ADI's European wafer production capacity and aligns with the company's goal of doubling its internal manufacturing capacity to enhance the resiliency of its global supply chain and better serve customer needs. This investment is expected to grow ADI's employment footprint in the mid-west region of Ireland by 600 new positions, a significant increase to ADI's current 1,500 employees in Ireland and 3,100 employees in Europe as a whole. This announcement comes a year after ADI announced a separate investment of EUR 100 million in ADI Catalyst, its 100,000 sq-ft custom-built facility for innovation and collaboration at its Limerick campus. Ireland is also home to ADI's main European Research and Development Center, which has generated more than 1,000 patents since its inception and has seeded ADI R&D sites throughout Europe in Spain, Italy, UK, Romania, and Germany.
|
IDCC | Hot Stocks05:07 EDT InterDigital signs new patent license agreement with Alps Alpine - InterDigital announced that it has signed a new patent license agreement with Alps Alpine Co. The deal covers Alps Alpine's range of devices under InterDigital's standard essential patents related to HEVC.
|
GLOB | Hot Stocks05:06 EDT Globant to acquire Pentalog, terms undisclosed - Globant announced that it has entered into a definitive agreement to acquire Pentalog. The acquisition will support Globant's plans to expand its footprint and services in France. Pentalog is working on over 250 digital products with some of the world's most innovative engineers. This combination will allow actual and potential clients of Globant and Pentalog to benefit from increased collaboration, scale-up solutions, and an enriched and broader value proposition. Founded in 1993 in Orleans, France, Pentalog houses 1,300 professionals in France, Romania, Moldova, Mexico, Vietnam, and the U.S., among other countries, and offers a robust value proposition including digital services to solve customers' business problems and a recruiting division to support customers' internal teams expansion. In its 30 years, Pentalog was able to build a strong business pipeline with close to 80% of its revenues coming from European accounts and the remaining revenues generated in North America. Pentalog's co-founder and CEO, Frederic Lasnier, will remain with Globant together with his partners and the larger Pentalog team. Completion of this transaction is subject to customary closing conditions.
|